title: Council Regulation (EC) No 1110/1999 of 10 May 1999 providing for duty-free treatment of specified pharmaceutical active ingredients bearing an international non-proprietary name (INN) from the World Health Organisation and specified products used for the manufacture of finished pharmaceutical products

text: 29. 5. 1999 EN Official Journal of the European Communities L 135/1 I (Acts whose publication is obligatory) COUNCIL REGULATION (EC) No 1110/1999 of 10 May 1999 providing for duty-free treatment of specified pharmaceutical active ingredients bearing an international non-proprietary name (INN) from the World Health Organisation and specified products used for the manufacture of finished phar- maceutical products THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Treaty establishing the European Community, and in particular Article 113 thereof, Having regard to the proposal from the Commission, (1) Whereas, in the course of the Uruguay Round negotiations, the Community and a number of countries discussed duty-free treatment of pharma- ceutical products; (2) Whereas the participants in those discussions concluded that, in addition to products falling within the Harmonised System (HS) Chapter 30 and HS Headings 2936, 2937, 2939 and 2941, duty- free treatment should be given to designated phar- maceutical active ingredients bearing an inter- national non-proprietary name (INN) from the World Health Organisation, as well as specified salts, esters and hydrates of such products, and also to designated products used for the production and manufacture of finished pharmaceutical products; (5) Whereas the second such review has taken place with the conclusion that additional INNs and products used for production and manufacture of finished be granted duty-free treatment and that the list of specified prefixes and suffixes for salts and esters of INNs should be expanded, pharmaceutical products should HAS ADOPTED THIS REGULATION: Article 1 As from 1 July 1999 the Community shall accord duty- free treatment for the INNs listed in Annex I as well as the salts, esters and hydrates of such products. Article 2 As from 1 July 1999 the Community shall accord duty- free treatment for the products used in the production finished pharmaceutical products and manufacture of listed in Annex II. (3) Whereas the results of the discussions, as set out in the Record of Discussions, were incorporated into the tariff schedules of the participants annexed to the Marrakesh Protocol to GATT 1994; (4) Whereas they also concluded that representatives of the World Trade Organisation (WTO) members party to the Record of Discussions would meet under the auspices of the Council for Trade in Goods of the WTO, normally at least once every three years, to review the product coverage with a view to including, by consensus, additional phar- maceutical products for tariff elimination; Article 3 As from 1 July 1999 the specified prefixes and suffixes of INNs eligible for duty-free treatment shall include those listed in Annex III. Article 4 This Regulation shall enter into force on the seventh day following that of its publication in the Official Journal of the European Communities. L 135/2 EN Official Journal of the European Communities 29. 5. 1999 This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 10 May 1999. For the Council The President H. EICHEL 29. 5. 1999 EN Official Journal of the European Communities L 135/3 ANNEX I Additional INNs to receive duty-free treatment CN code CAS RN Name CN code CAS RN Name 2844 40 30 74855-17-7 Iocanlidic acid (123 I) 2930 90 16 13189-98-5 Fudosteine 155798-07-5 Ioflupane (123 I) 136794-86-0 Iometopane (123 I) 94153-50-1 Mespiperone (11 C) 154427-83-5 178959-14-3 165942-79-0 157476-76-1 Samarium (153 Sm) lexi- dronam Technetium (99 m Tc) apci- tide Technetium (99 m Tc) nofe- tumomab merpentan Technetium (99m Tc) pintumomab 2906 19 00 131918-61-1 Paricalcitol 134404-52-7 Seocalcitol 2914 40 90 38398-32-2 Ganaxolone 2918 30 00 69956-77-0 Pelubiprofen 2922 19 90 82186-77-4 Lumefantrine 129612-87-9 Miproxifene 173324-94-2 Temiverine 2922 49 70 148553-50-8 Pregabalin 2922 50 00 141993-70-6 Eldacimibe 34391-04-3 Levosalbutamol 134865-33-1 Meluadrine 2924 10 00 146919-78-0 Opratonium iodide 138531-07-4 Sinapultide 2924 21 90 159910-86-8 Droxinavir 2924 29 90 138112-76-2 Agomelatine 891-60-1 Declopramide 175385-62-3 Lasinavir 105816-04-4 Nateglinide 78281-72-8 Nepafenac 172820-23-4 Pexiganan 150812-12-7 Retigabine 123441-03-2 Rivastigmine 2925 19 80 162706-37-8 Elinafide 129688-50-2 Minalrestat 2925 20 00 146978-48-5 Moxilubant 17035-90-4 Targinine 160677-67-8 Tresperimus 149820-74-6 Xemilofiban 2926 90 99 123548-56-1 Acreozast 2928 00 90 141184-34-1 Filaminast 95268-62-5 Upenazime 2930 90 70 159138-80-4 Cariporide 129453-61-8 Fulvestrant 137109-78-5 Orazipone 2932 19 00 142996-66-5 Furomine 2932 29 80 107724-20-9 Eplerenone 2932 99 70 61136-12-7 Almurtide 135038-57-2 Fasidotril 2932 99 80 169758-66-1 Robalzotan 2933 19 90 142155-43-9 Cizolirtine 2933 29 90 40077-57-4 Aviptadil 177563-40-5 Carafiban 173997-05-2 Nepicastat 2933 39 95 154229-19-3 Abiraterone 154541-72-7 Alinastine 125602-71-3 Bepotastine 159997-94-1 Biricodar 171655-91-7 Brasofensine 145599-86-6 Cerivastatin 166432-28-6 Clevidipine 120958-90-9 Dalcotidine 120014-06-4 Donepezil 83799-24-0 Fexofenadine 145216-43-9 Forasartan 170566-84-4 Lanepitant 159776-68-8 Linetastine 145414-12-6 Lirexapride 171049-14-2 Lotrafiban 141725-10-2 Milacainide 139886-32-1 Milameline 155418-06-7 Nolpitantium besilate 160492-56-8 Osanetant 157716-52-4 Perifosine 103922-33-4 Pibutidine 156137-99-4 Rapacuronium bromide 149926-91-0 Revatropate 162401-32-3 Roflumilast 158876-82-5 Rupatadine 159912-53-5 Sabcomeline 142001-63-6 Saredutant 172927-65-0 Sibrafiban 140944-31-6 Silperisone 149979-74-8 Terbogrel 154413-61-3 Ticolubant 135354-02-8 Xaliproden L 135/4 EN Official Journal of the European Communities 29. 5. 1999 CN code CAS RN Name CN code CAS RN Name 2933 40 10 151096-09-2 Moxifloxacin 154612-39-2 Palinavir 127254-12-0 Sitafloxacin 2933 40 90 143664-11-3 Elacridar 159989-64-7 Nelfinavir 139314-01-5 Quilostigmine 2933 59 70 136470-78-5 Abacavir 135637-46-6 Atizoram 156862-51-0 Belaperidone 132810-10-7 Blonanserin 59989-18-3 Eniluracil 164150-99-6 Fandofloxacin 167933-07-5 Flibanserin 160738-57-8 Gatifloxacin 150378-17-9 Indinavir 141549-75-9 Indisetron 130018-77-8 Levocetirizine 130636-43-0 Nifekalant 147149-76-6 Nolatrexed 152939-42-9 Opanixil 133432-71-0 Peldesine 137281-23-3 Pemetrexed 130800-90-7 Sipatrigine 148408-65-5 Sunepitron 103300-74-9 Taltirelin 175865-60-8 Valganciclovir 116308-55-5 Vatanidipine 2933 79 00 129722-12-9 Aripiprazole 164656-23-9 Dutasteride 156001-18-2 Embusartan 129300-27-2 Fabesetron 110958-19-5 Fasoracetam 134143-28-5 Glaspimod 155974-00-8 Ivabradine 149503-79-7 Lefradafiban 163250-90-6 Orbofiban 133737-32-3 Pagoclone 135729-56-5 Palonosetron 2933 90 60 150408-73-4 Pranazepide 137332-54-8 Tivirapine 2933 90 95 157182-32-6 Alatrofloxacin 153205-46-0 Asimadoline 123018-47-3 Atiprimod 135779-82-7 Bamaquimast 121104-96-9 Celgosivir 159776-69-9 Cemadotin 153438-49-4 Dapitant 140661-97-8 Deltibant 162301-05-5 Ecenofloxacin 143322-58-1 Eletriptan 158747-02-5 Frovatriptan 153436-22-7 Gavestinel 157476-77-2 Lagatide 153504-81-5 Licostinel 159776-70-2 Melagatran 127657-42-5 Minodronic acid 145375-43-5 Mitiglinide 122332-18-7 Mivobulin 156601-79-5 Nepaprazole 114856-44-9 Oberadilol 158364-59-1 Pumaprazole 144034-80-0 Rizatriptan 169312-27-0 Talviraline 94948-59-1 Tasonermin 2934 10 00 153242-02-5 Aseripide 136468-36-5 Foropafant 136381-85-6 Lintitript 155213-67-5 Ritonavir 122320-73-4 Rosiglitazone 2934 30 90 135003-30-4 Apadoline 2934 90 96 122384-88-7 Amlintide 108912-17-0 Atliprofen 154355-76-7 Atreleuton 135928-30-2 Beloxepin 153507-46-1 Bibapcitide 107233-08-9 Cevimeline 163252-36-6 Clevudine 118976-38-8 Dabelotine 143249-88-1 Dexefaroxan 154598-52-4 Efavirenz 155773-59-4 Ensaculin 165800-04-4 Eperezolid 148031-34-9 Eptifibatide 136087-85-9 Fidarestat 144245-52-3 Fomivirsen 68134-81-6 Gacyclidine 145508-78-7 Icopezil 117279-73-9 Israpafant 133242-30-5 Landiolol 113457-05-9 Ledoxantrone 165800-03-3 Linezolid 110143-10-7 Lodenosine 164178-54-5 Mazokalim 148564-47-0 Milfasartan 121032-29-9 Nelzarabine 29. 5. 1999 EN Official Journal of the European Communities L 135/5 CN code CAS RN Name CN code CAS RN Name 183747-35-5 Nepadutant 167305-00-2 Omapatrilat 176894-09-0 Omiloxetine 153168-05-9 Pleconaril 151126-32-8 Pramlintide 179474-81-8 Prucalopride 111974-69-7 Quetiapine 112887-68-0 Raltitrexed 135459-90-4 Ranelic acid 129791-92-0 Rifalazil 170902-47-3 Roxifiban 145574-90-9 Scopinast 143248-63-9 Sinitrodil 130403-08-6 Soretolide 131987-54-7 Tazomeline 110221-53-9 Temocaprilat 147650-57-5 Tererstigmine 159098-79-0 Tilnoprofen arbamel 131094-16-1 Trafermin 148998-94-1 Trecovirsen 141575-50-0 Vedaclidine 107452-89-1 Ziconotide 139264-17-8 Zolmitriptan 2935 00 90 154323-57-6 Almotriptan 151140-96-4 Avitriptan 138890-62-7 Brinzolamide 30236-32-9 Dexsotalol 141626-36-0 Dronedarone 159634-47-6 Ibutamoren 138384-68-6 Metesind 140695-21-2 Osutidine 129981-36-8 Sampatrilat 139755-83-2 Sildenafil 127373-66-4 Sivelestat 2937 10 00 177073-44-8 Choriogonadotropin alfa 150490-84-9 Follitropin beta 2937 22 00 123013-22-9 Amelometasone 2937 29 00 76675-97-3 Resocortol 2937 99 00 183552-38-7 Abarelix 140703-49-7 Avorelin 182212-66-4 Avotermin 165101-51-9 Becaplermin 157238-32-9 Cetermin 116094-23-6 insulin aspart 160337-95-1 insulin glargine 170851-70-4 Ipamorelin 158861-67-7 Pralmorelin 146706-68-5 Rismorelin 2938 90 90 150332-35-7 Pamaqueside 2939 50 00 136145-07-8 Arofylline 2939 90 90 149882-10-0 Lurtotecan 162652-95-1 Vinflunine 2940 00 90 132682-98-5 Glufosfamide 2941 10 90 151287-22-8 Tobicillin 2941 90 00 129639-79-8 Abafungin 135821-54-4 Ceftizoxime alapivoxil 101312-92-9 Valnemulin 121584-18-7 Valspodar 3002 10 118390-30-0 Interferon alfacon-1 3002 10 91 154361-48-5 Arcitumomab 179045-86-4 Basiliximab 158318-63-9 Bectumomab 156586-90-2 Cedelizumab 182912-58-9 Clenoliximab 156586-89-9 Edrecolomab 169802-84-0 Enlimomab pegol 167816-91-3 Faralimomab 167747-20-8 Felvizumab 171656-50-1 Igovomab 170277-31-3 Infliximab 174722-30-6 Keliximab 166089-32-3 Lintuzumab 162774-06-3 Nerelimomab 174722-31-7 Rituximab 167747-19-5 Sulesomab 180288-69-1 Trastuzumab 3002 10 95 161753-30-6 Daniplestim 142298-00-8 Emoctakin 142261-03-8 Hemogloblin crosfumaril 154248-96-1 Iroplact 137463-76-4 Milodistim 166089-33-4 Nagrestipen 113478-33-4 Nonacog alfa 145941-26-0 Oprelvekin 112721-39-8 Pifonakin 148883-56-1 Tifacogin 3003 20 00 123760-07-6 Zinostatin stimalamer 3507 90 90 151912-42-4 Pamiteplase 99821-47-3 Urokinase alfa 3907 20 99 186638-10-8 Pegmusirudin 3911 90 99 182815-43-6 Colesevelam 52757-95-6 Sevelamer 3913 90 80 83513-48-8 Danaparoid sodium L 135/6 EN Official Journal of the European Communities 29. 5. 1999 ANNEX II Additional pharmaceutical intermediates, namely compounds used for the manufacture of finished pharmaceutical products, to receive duty-free treatment CN code CAS RN Name 2844 40 30 82407-94-1 1-[4-(2-dimethylaminoethoxy)[14C]phenyl)]-1,2-diphenylbutan-1-ol 2903 59 90 7051-34-5 Bromomethylcyclopropane 2904 90 85 4714-32-3 1-nitro-4-(1,2,2,2-tetrachloroethyl)benzene 2905 22 90 1113-21-9 (6E,10E,14E)-3,7,11,15-tetramethylhexadeca-1,6,10,14-tetraen-3-ol 7212-44-4 3,7,11-trimethyldodeca-1,6,10-trien-3-ol 2905 29 90 2914-69-4 (S)-but-3-yn-2-ol 2905 49 10 1947-62-2 (2R,3R)-1,4-bis(mesyloxy)butane-2,3-diol 2905 50 20 148043-73-6 4,4,5,5,5-pentafluoropentan-1-ol 75-89-8 2,2,2-trifluoroethanol 2905 50 99 57090-45-6 (R)-3-chloropropane-1,2-diol 2907 19 00 27673-48-9 5,8-dihydro-1-naphthol 2909 30 90 3383-72-0 2-chloroethyl 4-nitrophenyl ether 2910 30 00 51594-55-9 (R)-1-chloro-2,3-epoxypropane 2910 90 00 129940-50-7 (S)-[(trityloxy)methyl]oxirane 2912 49 00 1620-98-0 3,5-di-tert-butyl-4-hydroxybenzaldehyde 2144-08-3 2,3,4-trihydroxybenzaldehyde 2914 50 00 28315-93-7 5-hydroxy-1,2,3,4-tetrahydro-1-naphthone 104-20-1 4-(4-methoxyphenyl)butan-2-one 1078-19-9 6-methoxy-1,2,3,4-tetrahydro-1-naphthone 2914 70 90 150587-07-8 21-benzyloxy-9-alpha-fluoro-11-beta,17-alpha-dihydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione 153977-22-1 trans-2-chloro-3-[4-(4-chlorophenyl)cyclohexyl]-1,4-naphthoquinone 151265-34-8 21-chloro-16-alpha-methylpregna-1,4,9(11)-triene-3,20-dione 534-07-6 1,3-dichloroacetone 2915 39 90 24085-06-1 2-acetoxy-5-acetylbenzyl acetate 37413-91-5 3,20-dioxopregna-1,4,9(11),16-tetraen-21-yl acetate 7753-60-8 17-alpha-hydroxy-3,20-dioxopregna-4,9(11)-diene-21-yl acetate 2915 90 80 18997-19-8 Chloromethyl pivalate 2916 20 00 3721-95-7 Cyclobutanecarboxylic acid 2916 31 00 132294-17-8 (1S,2S,3S)-2,3-bis(benzoyloxymethyl)cyclobutanol 132294-16-7 (2S,3S)-2,3-bis(benzoyloxymethyl)cyclobutanone 2916 39 00 141109-25-3 2-bromo-2-(2-chlorophenyl)acetic acid 119916-27-7 4,6-dibromo-3-fluoro-o-toluic acid 55332-37-1 (S)-2-(4-fluorophenyl)-3-methylbutyric acid 2417-72-3 Methyl 4-(bromomethyl)benzoate 4276-85-1 2-(2,4,6-triisopropylphenyl)acetic acid 2917 19 90 6065-63-0 Diethyl dipropylmalonate 28868-76-0 Dimethyl chloromalonate 2918 19 99 36394-75-9 (S)-alpha-chloroformylethyl acetate 157604-22-3 Disodium (2S,3R)-2-hydroxy-3-isobutylsuccinate 90315-82-5 Ethyl (R)-2-hydroxy-4-phenylbutyrate 29. 5. 1999 EN Official Journal of the European Communities L 135/7 CN code CAS RN Name 2918 29 90 168899-58-9 3-acetoxy-o-toluic acid 3943-89-3 Ethyl 3,4-dihydroxybenzoate 2918 30 00 302-97-6 3-oxoandrost-4-ene-17-beta-carboxylic acid 2918 90 90 157283-68-6 Isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(E)-(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but- 1-enyl}cyclopentyl]hept-5-enoate 70264-94-7 Methyl 4-(bromomethyl)-m-anisate 33924-48-0 Methyl 5-chloro-o-anisate 2920 90 10 208338-09-4 (4R,5R)-4,5-bis(mesyloxymethyl)-1,3,2-dioxathiolane 2,2-dioxide 35180-01-9 Chloromethyl isopropyl carbonate 16606-55-6 (R)-propylene carbonate 2920 90 85 31618-90-3 Diethyl (tosyloxy)methylphosphonate 2921 19 80 5407-04-5 3-chloropropyldimethylammonium chloride 2921 29 00 100-36-7 2-aminoethyldiethylamine 156886-85-0 N,NY-bis[3-(ethylamino)propyl]propane-1,3-diamine tetrahydrochloride 2921 30 10 167944-94-7 Cyclohexylammonium 1-[(S)-2-(tert-butoxycarbonyl)-3-(2- methoxyethoxy)propyl]cyclopentanecarboxylate 2921 43 00 2921 49 10 393-11-3 Alpha,alpha,alpha-trifluoro-4-nitro-m-toluidine 328-93-8 Alpha,alpha,alpha,alphaY,alphaY,alphaY-hexafluoro-2,5-xylidine 2921 49 90 132173-07-0 (Z)-N-[3-(3-chloro-4-cyclohexylphenyl)prop-2-enyl]-N-ethylcyclohexylamine hydrochloride 69385-30-4 2,6-difluorobenzylamine 129140-12-1 1-ethyl-1,4-diphenylbut-3-enylamine 166943-39-1 Methyl(4Y-nitrophenethyl)amine hydrochloride 81972-27-2 3-(trichlorovinyl)aniline hydrochloride 33881-72-0 Triethylaniline 2922 19 90 154598-58-0 (S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol 151851-75-1 (R)-2-amino-2-ethylhexan-1-ol 534-03-2 2-aminopropane-1,3-diol 54527-65-0 2-[benzyl(methyl)amino]ethyl acetoacetate 151807-53-3 (1RS,2RS,3SR)2,3-bis(benzoyloxymethyl)cyclobutylamine 83647-29-4 3-{(Z)-1-[4-(2-dimethylaminoethoxy)phenyl]-2-phenylbut-1-enyl}phenol 1159-03-1 5-(3-dimethylaminopropyl)-10,11-dihydrodibenzo[a,d]cyclohepten-5-ol 2922 30 00 2958-36-3 2-amino-2Y,5-dichlorobenzophenone 2922 49 70 128013-69-4 3-(aminomethyl)-5-methylhexanoic acid 35453-19-1 5-amino-2,4,6-triiodoisophthalic acid 67299-45-0 Cis-4-(benzyloxycarbonyl)cyclohexylammonium tosylate 1118-89-4 Diethyl L-glutamate hydrochloride 154772-45-9 Ethyl (S)-3-aminopent-4-ynoate hydrochloride 119916-05-1 Methyl 3-amino-4,6-dibromo-o-toluate 961-69-3 Potassium (R)-N-(3-ethoxy-1-methyl-3-oxoprop-1-enyl)-2-phenylglycine 2922 50 00 35205-50-6 4Y-benzyloxy-2-[(1-methyl-2-phenoxyethyl)amino]propiophenone hydrochloride 121524-09-2 Ethyl ((7S)-7-{[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}-5,6,7,8-tetrahydro-2-naphthyloxy)acetate hydrochloride 16589-24-5 4-[1-hydroxy-2-(methylamino)ethyl]phenol--L-tartaric acid (2:1) 59338-84-0 Methyl 4-amino-5-nitro-o-anisate 2924 10 00 90303-36-9 N-[N-(tert-butoxycarbonyl)-L-alanyl]-L-alanine hydrate 116833-20-6 2-(ethylmethylamino)acetamide L 135/8 EN Official Journal of the European Communities 29. 5. 1999 CN code CAS RN Name 2924 29 90 112522-64-2 4-acetamido-2Y-aminobenzanilide 24201-13-6 4-acetamido-5-chloro-o-anisic acid 27313-65-1 N-acetyl-3-(3,4-dimethoxyphenyl)-DL-alanine 40187-51-7 5-acetylsalicylamide 148051-08-5 5-amino-N,NY-bis[2-acetoxy-1-(acetoxymethyl)ethyl]-2,4,6-triiodoisophthalamide 76801-93-9 5-amino-N,NY-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide 41526-21-0 2Y-benzoyl-2-bromo-4Y-chloroacetanilide 91558-42-8 Benzyl (1-carbamoyl-2-hydroxypropyl)carbamate 1584-62-9 2-bromo-4Y-chloro-2Y-(2-fluorobenzoyl)acetanilide 168960-18-7 Tert-butyl (1R,4S)-4-(hydroxymethyl)cyclopent-2-enylcarbamate 50978-11-5 3,5-diacetamido-2,4,6-triiodobenzoic acid dihydrate 166518-60-1 N-[(2,6-diisopropylphenoxy)sulfonyl]-2-(2,4,6-triisopropylphenyl)acetamide 137246-21-0 N-(1-ethyl-1,4-diphenylbut-3-enyl)cyclopropanecarboxamide 52806-53-8 2-hydroxy-2-methyl-4Y-nitro-3Y-(trifluoromethyl)propionanilide 4093-29-2 Methyl 4-acetamido-o-anisate 176972-62-6 Methyl (1S,2S)-1-benzyl-3-chloro-2-hydroxypropylcarbamate 41844-71-7 Methyl N-(methoxycarbonyl)-L-phenylalaninate 153441-77-1 Methyl N-(phenoxycarbonyl)-L-valinate 2925 19 80 1075-89-4 8-azaspiro[4. 5]decane-7,9-dione 88784-33-2 1-benzyl hydrogen (S)-4-phthalimidoglutarate 2925 20 00 149177-92-4 4Y-amidinosuccinanilic acid hydrochloride 2926 90 99 39186-58-8 4-bromo-2,2-diphenylbutanenitrile 186038-82-4 Diethyl (1-cyano-3-methylbutyl)malonate 15760-35-7 3-methylenecyclobutanecarbonitrile 2928 00 90 192802-28-1 (S)-O-benzyllactaldehyde-N-(tert-butoxycarbonyl)hydrazone 84080-70-6 4-chloro-2-[(Z)-(methoxycarbonyl)methoxyimino]-3-oxobutyric acid 53016-31-2 13-ethyl-17-alpha-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one oxime 130580-02-8 trans-2Y-fluoro-4-hydroxychalcone O-[(Z)-2-(dimethylamino)ethyl]oxime--fumaric acid (2:1) 55819-71-1 (RS)-serinohydrazide hydrochloride 2929 90 00 139976-34-4 NY-alpha-(tert-butoxycarbonyl)-N-methoxy-N-methyl-NY-omega-nitro-L-argininamide 2188-18-3 NY-alpha-(tert-butoxycarbonyl)-NY-omega-nitro-L-arginine 92050-02-7 2,6-diisopropylphenyl sulfamate 2930 90 16 105996-54-1 N,NY-bis(trifluoroacetyl)-DL-homocystine 2930 90 70 157521-26-1 (S)-2-(acetylthio)-3-phenylpropionic acid--dicyclohexylamine (1:1) 148757-89-5 9-bromononyl 4,4,5,5,5-pentafluoropentyl sulfide 6320-03-2 o-chlorothiophenol 182149-25-3 N,NY-[dithiobis(o-phenylenecarbonyl)]bis-L-isoleucine 33174-74-2 2,2Y-dithiodibenzonitrile 87483-29-2 4-fluorobenzyl 4-(methylthio)phenyl ketone 162515-68-6 2-[1-(mercaptomethyl)cyclopropyl]acetic acid 4274-38-8 2-mercapto-5-(trifluoromethyl)anilinium chloride 62140-67-4 Methyl 5-(ethylsulfonyl)-o-anisate 1134-94-7 2-(phenylthio)aniline 29. 5. 1999 EN Official Journal of the European Communities L 135/9 CN code CAS RN Name 2931 00 95 17814-85-6 (4-carboxylbutyl)triphenylphosphonium bromide 1660-95-3 Tetraisopropyl methylenediphosphonate 2932 19 00 86087-23-2 (S)-tetrahydrofuran-3-ol 2932 29 80 23363-33-9 4Y-(benzyloxycarbonyl)-4Y-demethylepipodophyllotoxin 192704-56-6 11-alpha-hydroxy-7-alpha-(methoxycarbonyl)-3-oxopregn-4-ene-21,17-alpha-carbolactone 73726-56-4 11-alpha-hydroxy-3-oxopregna-4,6-diene-21,17-alpha-carbolactone 2932 99 70 170242-34-9 (S)-2-amino-5-(1,3-dioxolan-4-yl)valeric acid 57999-49-2 2-(3-bromophenoxy)tetrahydropyran 157518-70-2 (2R)-2-[(S)-2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl]-4-methylvaleric acid 114870-03-0 Methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1,4)-O-beta-D- glucopyranuronosyl-(1,4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl- (1,4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1,4)-2-deoxy-2-(sulfoamino)-6-(hydrogen sulfate)- alpha-D-glucopyranoside, decasodium salt 88128-61-4 (3aS,9aS,9bR)-3a-methyl-6-[2-(2,5,5-trimethyl-1,3-dioxan-2-yl)ethyl]-1,2,4,5,8,9,9a,9b-octahydro- 3aH-cyclopenta[a]naphthalene-3,7-dione 2932 99 80 130525-62-1 (4S,5R,6R)-5-acetamido-4-amino-6-[(1R,2R)-1,2,3-trihydroxypropyl]-5,6-dihydropyran-2-carboxylic acid 107188-37-4 2-(4-aminophenoxymethyl)-2,5,7,8-tetramethyl-4-oxochroman-6-yl acetate 69999-16-2 (2,3-dihydrobenzofuran-5-yl)acetic acid 107188-34-1 2,5,7,8-tetramethyl-2-(4-nitrophenoxymethyl)-4-oxochroman-6-yl acetate 2933 19 90 139756-01-7 1-methyl-4-nitro-3-propylpyrazole-5-carboxamide 59194-35-3 NY1-methyl-1H-pyrazole-1-carboxamidine hydrochloride 4023-02-3 Pyrazole-1-carboxamidine hydrochloride 2933 29 90 151012-31-6 3-(4-bromobenzyl)-2-butyl-4-chloro-1H-imidazol-5-ylmethanol 151257-01-1 2-butyl-1,3-diazaspiro[4. 4]non-1-en-4-one hydrochloride 152146-59-3 4-(2-butyl-5-formylimidazol-1-ylmethyl)benzoic acid 68282-49-5 2-butylimidazole-5-carbaldehyde 138401-24-8 4Y-[(2-butyl-4-oxo-1,3-diazaspiro[4. 4]non-1-en-3-yl)methyl]biphenyl-2-carbonitrile 2933 39 95 176381-97-8 (S)-N-[4-(4-acetamido-4-phenyl-1-piperidyl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide- -fumaric acid (1:1) 171764-07-1 (S)-2-amino-3,3-dimethyl-N-2-pyridylbutyramide 180250-77-5 (2S,3S)-3-amino-2-ethoxy-N-nitropiperidine-1-carboxamidine hydrochloride 65326-33-2 2-amino-3-pyridyl methyl ketone 142034-92-2 (1S,3S,4S)-1-azabicyclo[2. 2. 1]heptan-3-ol 21472-89-9 (+-)-1-azabicyclo[2. 2. 1]heptan-3-one 142034-97-7 (1R,4S)-1-azabicyclo[2. 2. 1]heptan-3-one 180050-34-4 (1S,4R)-1-azabicyclo[2. 2. 1]heptan-3-one O-[(Z)-(3-methoxyphenyl)ethynyl]oxime--maleic acid (1:1) 173050-51-6 (R)-N-(1-{3-[1-benzoyl-3-(3,4-dichlorphenyl)-3-piperidyl]propyl}-4-phenyl-4-piperidyl)-N- methylacetamide hydrochloride 188591-61-9 1-(4-benzyloxyphenyl)-2-(4-hydroxy-4-phenyl-1-piperidyl)propan-1-one 22065-85-6 1-benzylpiperidine-4-carbaldehyde 160588-45-4 10,10-bis[(2-fluoro-4-pyridyl)methyl]anthrone L 135/10 EN Official Journal of the European Communities 29. 5. 1999 CN code CAS RN Name 157688-46-5 2-[1-(tert-butoxycarbonyl)-4-piperidyl]acetic acid 2008-75-5 1-(2-chloroethyl)piperidinium chloride 5382-23-0 4-chloro-1-methylpiperidine hydrochloride 5326-23-8 6-chloronicotinic acid 168273-06-1 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidino-1H-pyrazole-3-carboxamide 7379-35-3 4-chloropyridine hydrochloride 77145-61-0 1-(6-chloro-2-pyridyl)-4-piperidylamine hydrochloride 56488-00-7 3-(cyanoimino)-3-piperidinopropiononitrile 193275-84-2 4-{4-[(11R)-3,10-dibromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11- yl]piperidinocarbonylmethyl}piperidine-1-carboxamide 193275-85-3 4-{4-[(11S)-3,10-dibromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11- yl]piperidinocarbonylmethyl}piperidine-1-carboxamide 875-35-4 2,6-dichloro-4-methylnicotinonitrile 153050-21-6 (S)-1-{2-[3-(3,4-dichlorophenyl)-1-(3-isopropoxyphenacyl)-3-piperidyl]ethyl}-4-phenyl-1- azoniabicyclo[2. 2. 2]octane chloride 35794-11-7 3,5-dimethylpiperidine 1452-94-4 Ethyl 2-chloronicotinate 49608-01-7 Ethyl 6-chloronicotinate 5223-06-3 2-(5-ethyl-2-pyridyl)ethanol 189894-57-3 1-[(1S,2S)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]-4-phenylpiperidin-4-ol methanesulfonate trihydrate 5006-66-6 6-hydroxynicotinic acid 118175-10-3 [4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methanol 179024-48-7 N-[(R)-9-methyl-4-oxo-1-phenyl-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]isonicotinamide 103577-66-8 3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethanol 5435-54-1 3-nitro-4-pyridone 4783-86-2 4-phenoxypyridine 40807-61-2 4-phenylpiperidin-4-ol 5005-36-7 2-phenyl-2-pyridylacetonitrile 6622-91-9 4-pyridylacetic acid hydrochloride 192329-80-9 4-(4-pyridyloxy)benzenesulfonic acid 192330-49-7 4-(4-pyridyloxy)benzenesulfonyl chloride hydrochloride 2933 40 10 119916-34-6 7-bromo-1-cyclopropyl-6-fluoro-5-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 170143-39-2 3-methyl hydrogen 7-chloro1,4-dihydro-4-oxoquinoline-2,3-dicarboxylate 136465-98-0 N-(-quinolylcarbonyl)-L-asparagine 2933 40 90 136522-17-3 (3S,4aS,8aS)-2-[2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline- 3-carboxamide 149057-17-0 (S)-N-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide hydrochloride 186537-30-4 (S)-N-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide sulfate 146362-70-1 2-{[1-(7-chloro-4-quinolyl)-5-(2,6-dimethoxyphenyl)-1H-pyrazol-3-yl]carbonylamino}adamantane-2- carboxylic acid 178680-13-2 Methyl {(1S,2R)-1-benzyl-3-[(3S,4aS,8aS)-3-(tert-butylcarbomoyl)decahydro-2-isoquinolyl]-2- hydroxypropyl}carbamate 181139-72-0 Methyl 2-[(S)-3-{(E)-3-[2-(7-chloro-2-quinolyl)vinyl]phenyl}-3-hydroxypropyl]benzoate 149968-11-6 Methyl 2-(3-{(E)-3-[2-(7-chloro-2-quinolyl)vinyl]phenyl}-3-oxopropyl)benzoate 74163-81-8 (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid 29. 5. 1999 EN Official Journal of the European Communities L 135/11 CN code CAS RN Name 2933 59 70 13889-98-0 1-acetylpiperazine 156126-53-3 (1R,2R,3S)-2-amino-9-[2,3-bis(benzoyloxymethyl)cyclobutyl]-9H-purin-6-one 147149-89-1 2-amino-5-bromo-6-methylquinazolin-4(1H)-one 172015-79-1 [(1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)cyclopent-2-enyl]methanol hydrochloride 171887-03-9 N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide 707-99-3 6-amino-9H-purin-9-ylethanol 14047-28-0 (R)-2-(6-animo-9H-purin-9-yl)-1-methylethanol 147127-20-6 (R)-[2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methylphoophonic acid 149950-60-7 6-benzyl-1-(ethoxymethyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione 156126-83-9 (1R,2R,3S)-9-[2,3-bis(benzoyloxymethyl)cyclobutyl]-6-iodo-9H-purin-2-ylamine 202138-50-9 Bis[(isoproplyloxycarbonloxy)methyl [R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methylphosphonate-fumaric acid (1:1) 179688-29-0 6,7-bis(2-methoxyethoxy)quinazolin-4(1H)-one 56-06-4 2,6-diaminopyrimidin-4-ol 150728-13-5 4,6-dichloro-5-(methoxyphenoxy)-2,2Y-bipyrimidinyl 188416-34-4 (2RS,3SR)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol- (1R,4S)-2-oxobornane-10-sulfonic acid (1:1) 171228-49-2 4-[4-(4-{4-[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydrofuran-3- ylmethyloxy]phenyl} piperazin-1-yl)phenyl]-1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-1,2,4-triazol-5(4H)-one 153537-73-6 (S)-2-(4-{[(2,7-dimethyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl](prop-2-ynyl)amino}-2- fluorobenzamido-4-(1H-tetrazol-5-yl)butyric acid 7280-37-7 Estropipate 112733-28-5 Ethyl [3-(4-bromo-2-fluorobenzyl)-7-chloro-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl)acetate 137234-87-8 6-ethyl-5-fluoropyrimidin-4(1H)-one 183319-69-9 (3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine hydrochloride 19690-23-4 6-iodo-1H-purin-2-ylamine 696-07-1 5-iodouracil 20535-83-5 6-methoxy-1H-purin-2-ylamine 65-71-4 5-methyluracil 184177-81-9 Phenyl {4-[4-(4-hydroxyphenyl)piperazin-1-yl]phenyl}carbamate 20980-22-7 2-(piperazin-1-yl)pyrimidine 154126-48-6 Tetrabutylammonium (6-iodo-1H-purin-2-yl)amide 66-22-8 Uracil 2933 79 00 175873-08-2 4-[(S)-3-amino-2-oxopyrrolidin-1-yl)benzonitrile hydrochloride 61865-48-3 (+-)-2-azabicyclo[2. 2. 1]hept-5-en-3-one 79200-56-9 (1R-4S)-2-azabicyclo[2. 2. 1]hept-5-en-3-one 159593-17-6 4-tert-butzylbenzyl 2-{(2R,3S)-3-[(R)-1-tert-butyldimethylsilyloxy)ethyl]-2-[(1R,3S)-3-methoxy-2- oxocyclohexyl]-4-oxoazetidin-1-yl{-2-oxoacetate 118289-55-7 6-chloro-5-(2-chloroethyl)indol-2(3H)-one 56341-37-8 6-chloroindol-2(3H)-one 175873-10-6 Ethyl 3-(3-{(S)-1-[4-(NY2-hydroxyamidino)phenyl]-2-oxopyrrolidin-3-yl}ureido)propionate 139122-76-2 4-(2-methyl-2-phenylhydrazino)-5,6-dihydro-2-pyridone 90776-59-3 4-nitroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3. 2. 0]hept-2-ene-2-carboxylate L 135/12 EN Official Journal of the European Communities 29. 5. 1999 CN code CAS RN Name 2933 90 50 179528-39-3 N-(biphenyl-2-yl)-4-[(2-methyl-4,5-dihydro-1H-imidazo[4,5-d] [1]benzazepin-6-yl)carbonyl]benzamide 139592-99-7 (Z)-1-[3-chloro-4-cyclohexylphenyl)pro-2-enyl]hexahydro-1H-azepin hydrochloride 2933 90 60 188978-02-1 (4R,5S,6S,7R)-1-[(3-amino-1H-indazol-5-yl)methyl]-4,7-dibenzyl-3-butyl-5,6-dihydroxylhexahydro-2H- 1,3-diazepin-2-one 70890-50-5 3-amino-7-methyl-5-phenyl-1H-1,4-benzodiazepin-2(3H)-one 106928-72-7 Tert-butyl (1S,9S)-6,10-dioxo-9-phthalimidooctahydropyridazo[1,2-a] [1,2]diazepine-1-carbocylate 2886-65-9 7-chloro-5-(2-fluorophenyl)-1H-1,4-benzodiazepin-2(3H)-one 2933 90 95 64137-52-6 [3-(1H-benzimidazol-2-yl)propyl]methylamine 120851-71-0 Trans-1-benzoyl-4-phenyl-L-proline 151860-16-1 Meso-3-benzyl-6-nitro-3-azabicyclo[3. 1. 0]hexane 65632-62-4 (S)-1-(benzyloxycarbonyl)hexahydropyridazine-3-carboxylic acid 143322-57-0 5-bromo-3-[(R)-1-methylpyrrolidin-2-ylmethyl]indole 31251-49-9 8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepata[1,2-b]pyridin-11-one 7250-67-1 N-(2-chloroethyl)pyrrolidine hydrochloride 170142-29-7 7-chloro-2(4-methoxy-2-methylphenyl)-2,3-dihydro-5H-pyridazino[4,5-b]quinoline-1,4,10-trione, sodium salt 100643-71-8 8-chloro-11-(4-piperidylidene)-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridine 194602-25-0 Dibenzyl 1-2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-(1H-1,2,4-triazol-1-ylmethyl)ethyl phosphate 176161-55-0 (5,6-dichloro-1H-benzimidazol-2-yl)isopropylamine 178619-89-1 6,7-dichloro-2,3-dimethoxyquinoxalin-5-ylamine 71208-55-4 diethyl (6-chloro-9H-carbazol-2-yl)methylmalonate 137733-33-6 NY,NY-diethyl-2-methyl-N-(6-phenyl-5-propylpyridazin-3-yl)propane-1,2-diamine--fumaric acid (2:3) 194602-27-2 Diphenyl[(S)-pyrrolidin-3-yl]acetonitrile hydrobromide 153435-96-2 Ethyl 4,6-dichloro-3-formylindole-2-carboxylate 185453-89-8 7-ethyl-3-[2-(trimethylsilyloxy)ethyl]indole 2380-94-1 4-hydroxyindole 182073-77-4 NY-[N-methoxycarbonyl-L-valyl]-N-[(S)-3,3,3-trifluoro-1-isopropyl-2-oxopropyl]-L-prolinamide 155322-92-2 (3R)-3-[(S)-1-(methylamino)ethyl]pyrrolidine 127105-49-1 Methyl (S)-2-amino-4-(1H-tetrazol-5-yl)butzyrate 132026-12-1 4-(2-methyl-1H-imidazo[4,5-c]pyridin-1-yl)benzoic acid 85440-79-5 2-methyl-1-nitrosoindoline 122852-75-9 5-methyl-2,3,4,5-terahydro-1H-pyrido[4,3-b]indol-1-one 190791-29-8 (5R,6S)-6-phenyl-5-[4-(2-pyrrolidinoethoxy)phenyl-5,6,7,8-tetrahydro-2-naphthol--(-)-tartaric acid (1:1) 59032-27-8 Sodium 1,2,3-triazole-5-thiolate 143722-25-2 2-(2-trityl-2H-tetrazol-5-yl)phenylboronic acid 2934 10 00 180144-61-0 3-{[4-(4-amidinophenyl)thiazol-2-yl] [1-(carboxymethyl)-4-piperidyl]amino}propionic acid 174761-17-2 Benzhydryl 7-{(Z)-2-[2-tert-butoxycarbonylamino)thiazol-4-yl]-4-(3-methylbut-2-enyloxycarbonyl)but- 2-enamido}-3-cephem-4-carboxylate 190841-79-3 Ethyl 3-({4-[4-(N-ethoxycarbonylamidino)phenyl]thiazol-2-yl} [1-(ethoxycarbonylmethyl)-4- piperidyl]amino)propionate 556-90-1 2-imino-1,3-thiazol-4-one 105889-80-3 Pivaloyloxymethyl 7-{(Z)-2-[2-(tert-butoxycarbonylamino)thiazo-4-yl]pent-2-enamido}-3- (carbamoyloxymethyl)-3-cephem-4-carboxylate 2295-31-0 Thiazolidine-2,4-dione 29. 5. 1999 EN Official Journal of the European Communities L 135/13 CN code CAS RN Name 2934 20 80 89604-92-2 Tert-butyl 2-{[1-(2-aminothiazol-4-yl)-2-(benzisothiazol-2-ylthio)-2- oxoethylidene]aminooxy}-2-methylpropionate 177785-47-6 (2S,3S)-3-methyl-2-(3-oxo-2,3-dihydro-1,2-benzisothiazol-2-yl)valeric acid 2934 90 96 160115-08-2 {(E)-[(6R,7R)-7-amino-2-carboxylato-8-oxo-thia-1-azabicyclo[4. 2. 0]oct-2-en-3-yl]allyl}(carbamoylmethyl) (ethyl)methylammonium 143491-57-0 (2R,5S)-4-amino-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one 80370-59-8 7-amino-3-(2-furoylthiomethyl)-3-cephem-4-carboxylic acid 177575-17-6 (S)-N-{5-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-1H-pyrimido[5,4-b] [1,4]thiazin-6-ethyl}-2-thenoyl]- L-glutamic acid 186521-45-9 (6S)-5-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimido[5,4-b] [1,4]thiazin- 6-yl)ethyl]thiophene-2-carboxylic acid 116833-10-4 (Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-[(fluoromethoxy)imino]acetic acid 38313-48-3 3Y,5Y-anydrothymidine 3083-77-0 1-(beta-D-arabinofuranosyl)pyrimidine-2,4(1H,3H)-dione 108895-45-0 3Y-azido-2Y,3Y-dideoxy-5-methylcytidine hydrochloride 7787-68-4 Benzhydryl 6-(4-methylbenzamido)penicillanate 4-oxide 157341-41-8 (2S)-N-[(R)-1-(1,3-benzodioxol-5-yl)butyl]-3,3-diethyl-2-{4-[(4-methylpiperazin-1-yl(carbonyl]phenoxyl}-4- oxoazetidine-1-carboxamide 122567-97-9 5Y-benzoyl-2Y,3Y-didehydro-3Y-deoxythymidine 158512-24-4 (3aS,8aR)-3-[(2R,4S)-2-benzyl-4,5-epoxyvaleryl]-2,2-dimethyl-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d]oxazole 168828-81-7 Benzyl (3-fluoro-4-morpholinophenyl)carbamate 14282-76-9 2-bromo-3-methylthiophene 184475-35-2 (3-chloro-4-fluorophenyl)[7-methocy-6-(3-morpholinopropoxy)quinazolin-4-yl]amine 63-37-6 Cytidine 5Y-(dihydrogen phosphate) 145514-04-1 (2R,4R)-4-(2,6-diamino-9H-purin-9-yl)-1,3-dioxolan-2-ylmethanol 177932-89-7 (4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(3-aminobenzyl)-5,6-dihydroxyhexahydro-2H-1,3-bis(3-aminobenzyl)- 5,6- dihydroxyhexahydro-2H-1,3-diazepin-2-one dimethanesulfonate 177575-19-8 Diethyl N-{5-[2-((6S)-2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimido[5,4-b] [1,4]thiazin-6-yl)ethyl]- 2-thenoyl}-L-glutamate 175712-02-4 [(3S,5S)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydrofuran-3-yl]methyl 4- chlorobenzenesulfonate 178357-37-4 (5aR,11bS)-9,10-dimethoxy-2-propyl-4,5,5a,6,7,11b-hexahydrobenzol[f]thieno[2,3-c] quinoline hydrochloride 186521-41-5 Dimethyl 2-[(S)-1-(tert-butoxycarbonylaminomethyl)-2-(5-ethoxycarbonyl-2-thienyl)propylthio]malonate 84915-43-5 (3S)-2,2-dimethyl-1,4-thiazinane-3-carboxylic acid 3206-73-3 DL-5-(1,2-dithiolan-3-yl)valeramide 186521-40-4 Ethyl 5-[(3S)-3-(acetylthio)-4-(tert-butoxycarbonylamino)butyl]thiophene-2-cartboxylate 208337-84-2 Ethyl 5-[(3R)-4-amino-3-hydroxybutyl]thiophene-2-carboxylate 186521-44-8 Ethyl (6S)-5-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimido[5,4-b] [1,4] thiazin-6-yl)ethyl]thiophene-2-carboxylate 208337-82-0 Ethyl 5-(but-3-enyl)thiophene-2-carboxylate 186521-38-0 Ethyl 5-[(3R)-4-(tert-butoxycarbonylamino)-3-hydroxybutyl]thiophene-2-carboxylate 186521-39-1 Ethyl 5-[(3R)-4-(tert-butoxycarbonylamino)-3-(mesyloxy)butyl]thiophene-2-carboxylate L 135/14 EN Official Journal of the European Communities 29. 5. 1999 CN code CAS RN Name 208337-83-1 Ethyl 5-[(3R)-3,4-dihydroxybutyl]thiophene-2-carboxylate 143468-96-6 Ethyl hydrogen (2-thienylmethyl)malonate 63877-96-3 2-(4-fluorobenzyl)thiophene 112984-60-8 (+-)-6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-4H-[1,3]thiazetol[3,2-a]quinoline-3-carboxylic acid 4691-65-0 Inosine 5Y-disodium phosphate 167304-98-5 Methyl (4S,7S,10aS)-4-amino-5-oxooctahydr-7H-pyrido[2,1-b] [1,3]thiazepine-7-carboxylate 130209-90-4 Methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl]acetate hydrochloride 147086-83-7 N-[(4S,6S)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-yl]acetamide 181696-73-1 5-methyl-3,4-diphenyl-4,5-dihydroisoxazol-5-ol 186521-42-6 Methyl (S)-6-{2-[5-ethoxycarbonyl)-2-thienyl]ethyl}-3-oxo1,4-thiazinane-2-carboxylate 59804-25-0 Methyl 4-hydroxy-2-methyl-2H-thieno[2,3-e] [1,2]thiazine-3-carboxylate 1,1-dioxide 78850-37-0 Methyl (3aR,4R,7aR)-2-methyl-4-[1S,2R)-1,2,3-triacetoxypropyl]-3a,7a-dihydro-4H-pyrano[3,4-d] oxazole-6-carboxylate 39925-10-5 Methyl 1-(2,3,5-tri-O-acetyl-betal-D-ribuofuranosyl)-1H-1,2,4-triazole-3-carboxylate 1463-10-1 5-methyluridine 25954-21-6 5-methyluridine hemihydrate 28783-41-7 4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride 50-89-5 Thymidine 2935 00 90 183556-68-5 (S)-N-{(1S,2R)-3-[(1,3-benzodioxol-5-ylsulfonyl) (isobutyl)amino]-1-benzyl-2-hydroxypropyl}-3,3- dimethyl-2-(sarcosylamino)butyramide 6292-59-7 4-tert-butylbenzenesulfonamide 150375-75-0 NY-{(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-[(3,4-dimethoxyphenyl)sulfonyl]-3-hydroxy-2,3-dihydro-1H- indol-2-ylcarbonyl}-L-prolinamide 180200-68-4 4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide 192329-83-2 (3S)-2,2-dimethyl-4-[4-(4-pyridyloxy)phenylsulfonyl]-1,4-thiazinane-3-carboxylic acid 194602-23-8 2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]benzoic acid 179524-67-5 (S)-2-{3-[2-fluorobenzyl)sulfonylamino]-2-oxo-2,3-dihydro-1-pyridyl}-N-(1-formyl-4-guanidinobutyl)acetamide 17852-52-7 4-hydrazonobenzenesulfonamide hydrochloride 192329-42-3 (S)-N-hydroxy-2,2-dimethyl-4-[4-(4-pyridyloxy)phenylsulfonyl]-1,4-thiazinane-3-carboxamide 100632-57-3 4-[(4-mesylamino)phenyl]-4-oxobutyric acid 66644-80-2 3-methoxy-5-sulfamoyl-o-anisic acid 147200-03-1 N-[(4S,6S)-6-methyl-7,7-dioxo-2-sulfamoyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-yl]acetamide 106820-63-7 Methyl 3-[(methoxycarbonylmethyl)sulfamoyl]thophene-2-carboxylate 181695-72-7 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide 198470-85-8 N-[4-(5-methyl-3-phenylisoxazol-4-yl)phenylsulfonyl]propionamide, sodium salt 33045-52-2 Methyl 5-sulfamoyl-o-anisate 33288-71-0 5-methyl-N-[4-(sulfamoyl)phenethyl]pyrazine-2-carboxamide 161814-49-9 (3S)-tetrahydrofuran-3-yl (IS,2R)-3-[4-aminophenylsulfonyl) (isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate 169590-42-5 4-[5-p-tolyl)-3-trifluromethyl)-1H-pyrazol-1-yl]benzenesulfonamide 29. 5. 1999 EN Official Journal of the European Communities L 135/15 CN code CAS RN Name 2938 90 90 104443-62-1 1-O-[O-(N-acetyl-alpha-neuraminosyl)-(2,3)-O-[O-beta-D-galactopyranosyl-(1,3)-2-acetamido-2- deoxy-beta-D-galactopyranosyl-(1,4)]-O-beta-D-galactopyranosyl-(1,4)-beta-D-glucopyranosyl]ceramide 104443-57-4 1-O-[O-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1,4)-O-(N-acetyl-alpha-neurami- nosyl)-(2,3)-O-beta-D-galactopyranosyl-(1,4)-beta-D-glucopyranosyl]ceramide 196085-62-8 N-{[(1R,2R)-1-[O-(N-acetyl-alpha-neuraminosyl)-(2,3)-O-2-acetamido-2-deoxy-beta-D-galactopyranosyl- (1,4)-O-beta-D-galactopyranosyl-(1,4)-beta-D-glucopyranosyloxymethyl]-2-hydroxy-3- formylpropyl}stearamide 2939 10 00 41444-62-6 Codeine phosphate hemihydrate 54417-53-7 (R)-1,2,3,4-tetrahydropapaverine hydrochloride 2939 90 90 51-55-8 92-13-7 atropine pilocarpine 2940 00 90 182410-00-0 Beta-cyclodextrin sulfobutyl ethers, sodium salts 24259-59-4 L-ribose 4132-28-9 2,3,4,6-tetra-O-benzyl-D-glucose 80312-55-6 2,3,4,6-tetra-O-benzyl-1-O-(trimethylsilyl)-beta-D-glucose 3002 10 95 116638-33-6 SC-59735 193700-51-5 SC-70935 3003 90 195993-11-4 Hemocyanins, megathura crenulata, reaction products with 1-O-[O-2-acetamido-2-deoxy-beta-D-galacto- pyranosyl-(1,4)-O-(N-ayetyl-alpha-neuraminosyl)-(2,3)]-O-beta-D-galactopyranosyl- (1,4)-beta-D-glucopyranose 114256-04-04 1-(28-{O-D-apio-beta-D-furanosyl-(1,3)-O-beta-D-xylopyranosyl-(1,4)-O-6-deoxy-alpha-L- mannopyranosyl)-(1,2)-4-O-(5-alpha-L-arabinofuranosyloxy-3-hydroxy-6-methyloctanoyloxy)- 3-hydroxy-6-methyloctanoyl]-6-deoxy-beta--galactopyranosyloxy}- 16-alpha-hydroxy-23-beta, 28- dioxoolean-12-en-3-beta-yl)-O-beta-D-galactopyranosyl-(1,2)-O-beta-D-xylopyranosyl-(1,3)-beta-D- glucopyranosiduronic acid 3006 30 00 155773-56-1 Ferristene 3507 90 90 9002-12-4 Urate oxidase ANNEX III Additions to the list of prefixes and suffixes which, in combination with the INNs, describe salts, esters or hydrates of INNs Benzoate Difumarate Dipivoxil Monobenzoate Tetraisopropyl


title: Neuvoston asetus (EY) N:o 1003/1999, annettu 10 päivänä toukokuuta 1999, lopullisten polkumyynti- ja tasoitustullien käyttöönotosta Norjasta peräisin olevan viljellyn merilohen tuonnissa annetun asetuksen (EY) N:o 772/1999 muuttamisesta

eurovoc_concepts:
Bulgaria
ECSC
export
export monitoring
iron and steel product

formats: html pdf print

text: 13. 5. 1999 FI Euroopan yhteis(cid:148)jen virallinen lehti L 123/19 NEUVOSTON ASETUS (EY) N:o 1003/1999, annettu 10 p(cid:132)iv(cid:132)n(cid:132) toukokuuta 1999, lopullisten polkumyynti- ja tasoitustullien k(cid:132)ytt(cid:148)(cid:148)notosta Norjasta per(cid:132)isin olevan viljellyn merilohen tuonnissa annetun asetuksen (EY) N:o 772/1999 muut- tamisesta EUROOPAN UNIONIN NEUVOSTO, joka ottaa huomioon Euroopan yhteis(cid:148)n perustamissopi- muksen, ottaa huomioon polkumyynnill(cid:132) muista kuin Euroopan yhteis(cid:148)n j(cid:132)senvaltioista tapahtuvalta tuonnilta suojautumi- sesta 22 p(cid:132)iv(cid:132)n(cid:132) joulukuuta 1995 annetun neuvoston asetuksen (EY) N:o 384/96 (1) ja erityisesti sen 8 artiklan 9 kohdan ja 9 artiklan, ottaa huomioon muista Euroopan yhteis(cid:148)n j(cid:132)senvaltioista tapahtuvalta tuetulta tuonnilta suojautumisesta 6 p(cid:132)iv(cid:132)n(cid:132) lokakuuta 1997 annetun neuvoston asetuksen (EY) N:o 2026/97 (2) ja erityisesti sen 13 artiklan 9 kohdan ja 15 artiklan, ottaa huomioon komission ehdotuksen, komission kuultua neuvoa-antavaa komiteaa, joka on tehty sek(cid:132) katsoo seuraavaa: (1) (2) (3) A. V(cid:142)LIAIKAISET TULLIT Komissio hyv(cid:132)ksyi p(cid:132)(cid:132)t(cid:148)ksell(cid:132) 97/634/EY (3) sitou- mukset, joita Norjan kuningaskunta ja 190 norja- laista viej(cid:132)(cid:132) olivat tarjonneet kahdella erillisell(cid:132) Euroopan yhteis(cid:148)jen virallisessa lehdess(cid:132) julkais- vireille pantujen polku- tulla myynti(cid:132) ja tuettua tuontia koskevien tutkimusten yhteydess(cid:132). ilmoituksella (4) ensimm(cid:132)iselle Sitoumuksissa m(cid:132)(cid:132)r(cid:132)t(cid:132)(cid:132)n, ett(cid:132) nelj(cid:132)nnesvuosittain annettavan, kaikkea etuyhteytt(cid:132) vailla olevalle yhteis(cid:148)n asiakkaalle suuntautuvaa myynti(cid:132) koskevan ilmoituksen toimittamatta j(cid:132)tt(cid:132)- mist(cid:132) m(cid:132)(cid:132)r(cid:132)ajassa pidet(cid:132)(cid:132)n sitoumuksen rikkomi- sena kaikissa muissa paitsi ylivoimaisen esteen tapauksissa; sama koskee sen velvoitteen laimin- ly(cid:148)nti(cid:132), jonka mukaan asianomainen tuote on myyt(cid:132)v(cid:132) yhteis(cid:148)n markkinoilla v(cid:132)hint(cid:132)(cid:132)n sitou- muksessa vahvistetuilla v(cid:132)himm(cid:132)ishinnoilla. Kymmenen norjalaista toimittanut ilmoitusta m(cid:132)(cid:132)r(cid:132)ajassa vuoden 1998 toisen nelj(cid:132)n- neksen osalta tai ei toimittanut ilmoitusta lainkaan, yrityst(cid:132) ei (1) EYVL L 56, 6. 3. 1996, sellaisena kuin se on s. 1, asetus viimeksi muutettuna asetuksella (EY) N:o 905/98 (EYVL L 128, 30. 4. 1998, s. 18). (2) EYVL L 288, 21. 10. 1997, s. 1. (3) EYVL L 267, 30. 9. 1997, s. 81, p(cid:132)(cid:132)t(cid:148)s sellaisena kuin se on viimeksi muutettuna p(cid:132)(cid:132)t(cid:148)ksell(cid:132) (EY) N:o 2249/98 (EYVL L 282, 20. 10. 1998, s. 57). (4) EYVL C 235, 31. 8. 1996, s. 18 ja EYVL C 235, 31. 8. 1996, s. 20. (4) (5) (6) (7) ja kaksi norjalaista viej(cid:132)(cid:132) n(cid:132)ytt(cid:132)(cid:132) myyneen asian- omaista tuotetta yhteis(cid:148)n markkinoilla sitoumuk- sessa vahvistettua v(cid:132)himm(cid:132)ishintaa alhaisemmalla hinnalla. T(cid:132)m(cid:132)n perusteella komissiolla on aihetta uskoa, ett(cid:132) kyseiset kaksitoista yrityst(cid:132) olivat rikkoneet sitoumustensa ehtoja. T(cid:132)m(cid:132)n vuoksi komissio otti asetuksella (EY) N:o 82/1999 (5) j(cid:132)ljemp(cid:132)n(cid:132) ’v(cid:132)liaikaista tullia koskeva asetus’, k(cid:132)ytt(cid:148)(cid:148)n v(cid:132)liaikaiset polkumyynti- ja tasoi- tustullit kyseisen asetuksen liitteess(cid:132) lueteltujen kuuden (alun perin kahdentoista) yrityksen viem(cid:132)n CN-koodeihin ex 0304 10 13, ex 0302 12 00, ex 0303 22 00 ja ex 0304 20 13 kuuluvan Norjasta per(cid:132)isin olevan viljellyn merilohen tuonnissa. kyseiset Komissio yritykset p(cid:132)(cid:132)t(cid:148)ksen 97/634/EY liitteest(cid:132), joissa luetellaan yritykset, joiden tarjoama sitoumus on hyv(cid:132)ksytty. asetuksella samalla poisti B. MY(cid:153)HEMPI MENETTELY niist(cid:132) Kaikille v(cid:132)liaikaisten tullien soveltamisalaan kuulu- ville kahdelletoista norjalaisyritykselle ilmoitettiin ja kirjallisesti huomioista, joiden perusteella kyseiset v(cid:132)liaikaiset tullit oli otettu k(cid:132)ytt(cid:148)(cid:148)n. Yrityksille annettiin tilai- suus esitt(cid:132)(cid:132) huomautuksensa ja pyyt(cid:132)(cid:132) saada tulla kuulluksi. olennaisista tosiasioista Yhdeks(cid:132)n asianomaista norjalaista yrityst(cid:132) toimitti asiaa koskevia kirjallisia huomautuksia v(cid:132)liaikaista tullia koskevassa asetuksessa asetetussa m(cid:132)(cid:132)r(cid:132)ajassa ja viisi yrityst(cid:132) pyysi saada tulla kuulluiksi; niille annettin t(cid:132)h(cid:132)n mahdollisuus. Lis(cid:132)ksi Norwegian Seafood Association -j(cid:132)rjest(cid:148) esitti huomautuksia kahden v(cid:132)liaikaisten toimenpiteiden soveltamis- alaan kuuluvan yrityksen puolesta. N(cid:132)iden kirjal- listen huomautusten vastaanottamisen j(cid:132)lkeen komissio hankki ja tarkisti kaikki kyseisen ilmeisen rikkomisen lopullista m(cid:132)(cid:132)ritt(cid:132)mist(cid:132) varten tarpeel- lisina pit(cid:132)m(cid:132)ns(cid:132) tiedot. (5) EYVL L 8, 14. 1. 1999, sellaisena kuin se on s. 8, asetus muutettuna asetuksella (EY) N:o 929/1999 (EYVL L 115, 4. 5. 1999, s. 13). L 123/20 FI Euroopan yhteis(cid:148)jen virallinen lehti 13. 5. 1999 (8) T(cid:132)lt(cid:132) osin komission tutkimuksissa vahvistettiin, ett(cid:132) kuusi yrityst(cid:132), joiden osalta oli otettu k(cid:132)ytt(cid:148)(cid:148)n v(cid:132)liaikaiset toimenpiteet, ei ollut rikkonut sitou- mustaan, ja ett(cid:132) ne olisi merkitt(cid:132)v(cid:132) uudelleen luet- teloon yrityksist(cid:132), joihin ei sovelleta polkumyynti- viejille ja tasoitustoimenpiteit(cid:132). Asianomaisille ilmoitettiin kirjallisesti niist(cid:132) olennaisista tosi- asioista ja huomioista, joiden perusteella komissio aikoi hyv(cid:132)ksy(cid:132) niiden sitoumukset uudelleen. Kuudelle muulle v(cid:132)liaikaisten toimenpiteiden kohteena olleelle yritykselle ilmoitettiin niist(cid:132) olennaisista tosiasioista ja huomioista, joiden perus- vahvistaa peruuttaneensa teella komissio aikoi hyv(cid:132)ksynt(cid:132)ns(cid:132) niiden sitoumusten osalta ja suosi- tella lopullisten polkumyynti- ja tasoitustullien k(cid:132)ytt(cid:148)(cid:148)nottoa sek(cid:132) v(cid:132)liaikaisten tullien vakuutena olevia m(cid:132)(cid:132)rien lopullista kantamista. Niille annet- tiin my(cid:148)s m(cid:132)(cid:132)r(cid:132)aika, jonka kuluessa ne voivat tehd(cid:132) huomautuksia t(cid:132)m(cid:132)n ilmoituksen johdosta. (9) Komission asiaa koskevat p(cid:132)(cid:132)telm(cid:132)t tarkemmin asetuksessa (EY) N:o 929/1999. esitet(cid:132)(cid:132)n (10) Esitettyjen huomautusten perusteella ei kuitenkaan jonka mukaan t(cid:132)m(cid:132)n ole muutettu p(cid:132)(cid:132)telm(cid:132)(cid:132), asetuksen liitteess(cid:132) I lueteltujen kuuden yrityksen viem(cid:132)n Norjasta per(cid:132)isin olevan viljellyn merilohen tuonnissa olisi otettava k(cid:132)ytt(cid:148)(cid:148)n lopulliset polku- myynti- ja tasoitustullit. tasoitustullien tasoksi ja lajiksi sama kuin asetuk- sessa (EY) N:o 772/1999 (3). D. V(cid:142)LIAIKAISTEN TULLIEN LOPULLINEN KANTAMINEN (14) Kuuden viej(cid:132)n todettiin rikkoneen sitoumuksiaan. T(cid:132)st(cid:132) syyst(cid:132) katsotaan, ett(cid:132) n(cid:132)iden viejien osalta on tarpeen kantaa lopullisesti v(cid:132)liaikaisten polku- myynti- ja tasoitustullien vakuutena olevat m(cid:132)(cid:132)r(cid:132)t lopullisten tullien tasoisina. E. ASETUKSEN (EY) N:o 772/1999 LIITTEEN MUUTTAMINEN joiden sitoumukset on hyv(cid:132)ksytty, (15) Kaksi norjalaista viej(cid:132)(cid:132), Saga Lax Nord AS ja Hydro Seafood Sales AS, jotka sis(cid:132)ltyv(cid:132)t luettelon yrityk- sist(cid:132), ilmoitti komissiolle, ett(cid:132) yritysten nimet on muutettu seuraaviksi: Prima Nor AS ja Hydro Seafood Norway AS. Ne pyysiv(cid:132)t, ett(cid:132) kyseiset muutokset teht(cid:132)isiin my(cid:148)s joihin ei sovelleta polkumyynti- ja tasoitustulleja. Komissio on vahvistanut, ett(cid:132) yritysten rakenne ei ole muut- tunut tavalla, joka edellytt(cid:132)isi tarkempaa tutkimusta sen suhteen, voidaanko niiden antamia sitoumuksia edelleen pit(cid:132)(cid:132) hyv(cid:132)ksytt(cid:132)vin(cid:132). luetteloon yrityksist(cid:132), C. LOPULLISET TULLIT (16) (11) Sitoumuksiin johtaneet tutkimukset p(cid:132)(cid:132)tettiin polkumyynnin ja vahingon lopullisen m(cid:132)(cid:132)rityksen j(cid:132)lkeen asetuksella (EY) N:o 1890/97 (1) ja tuonnin tukemisen ja vahingon lopullisen m(cid:132)(cid:132)rityksen j(cid:132)lkeen asetuksella (EY) N:o 1891/97 (2). (12) Asetuksen (EY) N:o 384/96 8 artiklan 10 kohdan ja asetuksen (EY) N:o 2026/97 13 artiklan 10 kohdan mukaisesti polkumyynti- ja tasoitustulli on vahvis- tettava parhaiden k(cid:132)ytett(cid:132)viss(cid:132) olevien tietojen perusteella. (13) T(cid:132)m(cid:132)n vuoksi ja asetuksen (EY) N:o 1890/97 johdanto-osan 107 kappale ja asetuksen (EY) N:o 1891/97 johdanto-osan 149 kappale huomioon ottaen pidet(cid:132)(cid:132)n tarkoituksenmukaisena vahvistaa ja k(cid:132)ytt(cid:148)(cid:148)n otettavien lopullisten polkumyynti- (1) EYVL L 267, 30. 9. 1997, s. 1, asetus sellaisena kuin se on viimeksi muutettuna asetuksella (EY) N:o 2052/98 (EYVL L 264, 29. 9. 1998, s. 17). (2) EYVL L 267, 30. 9. 1997, s. 1, asetus sellaisena kuin se on viimeksi muutettuna asetuksella (EY) N:o 2052/98 (EYVL L 264, 29. 9. 1998, s. 17). Edell(cid:132) todetun perusteella katsotaan, ett(cid:132) asetuksen (EY) N:o 772/1999 liite, jossa lueteltuihin osapuo- liin ei sovelleta tullia, olisi muutettava niin, ett(cid:132) t(cid:132)m(cid:132)n asetuksen liitteess(cid:132) I luetellut yritykset eiv(cid:132)t en(cid:132)(cid:132) olisi vapautettuja tulleista. Mainittua liitett(cid:132) olisi muutettava my(cid:148)s niin, ett(cid:132) siin(cid:132) otetaan huomioon Saga Lax Nord AS -yrityksen nimen muuttuminen Prima Nor AS:ksi ja Hydro Seafood Sales AS -yrityksen nimen muuttuminen Hydro Seafood Norway AS:ksi, ON ANTANUT T(cid:142)M(cid:142)N ASETUKSEN: 1 artikla Korvataan asetuksen (EY) N:o 772/1999 liite t(cid:132)m(cid:132)n asetuksen liitteell(cid:132) II. (3) EYVL L 101, 16. 4. 1999, s. 1. 13. 5. 1999 FI Euroopan yhteis(cid:148)jen virallinen lehti L 123/21 2 artikla Kannetaan lopullisesti t(cid:132)m(cid:132)n asetuksen liitteess(cid:132) I lueteltujen yritysten viem(cid:132)n ja CN- koodeihin ex 0302 12 00 (Taric-koodi 0304 10 13*19), ex 0303 22 00 (Taric-koodi 0303 22 00*19), ja ex 0304 20 13 (Taric-koodi 0304 20 13*19) kuuluvan Norjasta per(cid:132)isin olevan viljellyn (muun kuin luonnonvaraisen) merilohen tuonnissa asetuksella (EY) N:o 82/1999 k(cid:132)ytt(cid:148)(cid:148)n otettujen v(cid:132)liaikaisten polku- myynti- ja tasoitustullien vakuutena olevat m(cid:132)(cid:132)r(cid:132)t. 0302 12 00*19), ex 0304 10 13 (Taric-koodi T(cid:132)m(cid:132) asetus tulee voimaan sit(cid:132) p(cid:132)iv(cid:132)(cid:132) seuraavana p(cid:132)iv(cid:132)n(cid:132), jona se julkaistaan Euroopan yhteis(cid:148)jen virallisessa lehdess(cid:132). 3 artikla T(cid:132)m(cid:132) asetus on kaikilta osiltaan velvoittava, ja sit(cid:132) sovelletaan sellaisenaan kaikissa j(cid:132)sen- valtioissa. Tehty Brysseliss(cid:132) 10 p(cid:132)iv(cid:132)n(cid:132) toukokuuta 1999. Neuvoston puolesta H. EICHEL Puheenjohtaja Luettelo yrityksist(cid:132), joihin sovelletaan lopullisia polkumyynti- ja tasoitustulleja LIITE I Sitoumuksen numero 1 5 30 65 159 171 Yrityksen nimi Taric-lis(cid:132)koodi A. Ovrekotnes AS Alsvag Fiskeprodukter A/S Brødrene Remo A/S Hitramat & Delikatesse AS Seacom Nord AS Stavanger Røkeri AS 8095 8098 8128 8154 8270 8282 L 123/22 FI Euroopan yhteis(cid:148)jen virallinen lehti 13. 5. 1999 LIITE II Luettelo yrityksist(cid:132), jotka vapautetaan lopullisista polkumyynti- ja tasoitustulleista Sitoumuksen numero Yrityksen nimi Taric-lis(cid:132)koodi 3 7 8 11 13 14 15 16 17 20 21 22 23 24 26 27 28 31 32 33 35 36 39 41 42 43 44 46 47 48 50 51 52 53 Agnefest Seafood Aqua Export A/S Aqua Partner A/S Arctic Group International Artic Superior A/S Arne Mathiesen A/S A/S Aalesundfisk A/S Austevoll Fiskeindustri A/S Keco A/S Refsnes Fiskeindustri A/S West Fish Ltd Astor A/S Atlantic King Stranda A/S Atlantic Seafood A/S Borkowski & Rosnes A/S Brødrene Aasjord A/S Brødrene Eilertsen A/S Christiansen Partner A/S Clipper Seafood A/S Coast Seafood A/S Dafjord Laks A/S Delfa Norge A/S Domstein Salmon A/S Ecco Fisk & Delikatesse Edvard Johnsen A/S Eurolaks AS Euronor AS Fiskeforsyningen AS Fjord Aqua Group AS Fjord Trading Ltd AS Fossen AS Fresh Atlantic AS Fresh Marine Company AS Fryseriet AS 8325 8100 8101 8109 8111 8112 8113 8114 8115 8118 8119 8120 8121 8122 8124 8125 8126 8129 8130 8131 8133 8134 8136 8138 8139 8140 8141 8143 8144 8145 8147 8148 8149 8150 13. 5. 1999 FI Euroopan yhteis(cid:148)jen virallinen lehti L 123/23 Sitoumuksen numero Yrityksen nimi Taric-lis(cid:132)koodi 58 60 61 62 66 67 72 75 76 77 79 80 82 83 85 87 92 93 96 98 99 100 101 104 105 107 108 111 112 113 114 115 116 119 120 121 122 123 124 126 Grieg Seafood AS Haafa fisk AS Hallvard Lerøy AS Herøy Filetfabrikk AS Hydro Seafood Norway AS Hydrotech-gruppen AS Inter Sea AS Janas AS Joh. H. Pettersen AS Johan J. Helland AS Karsten J. Ellingsen AS Kr. Kleiven & Co. AS Labeyrie Norge AS Lafjord Group AS Leica Fiskeprodukter Lofoten Seafood Export AS Marine Seafood AS Marstein Seafood AS Memo Food AS Midsundfisk AS Myre Sjømat AS Naco Trading AS Namdal Salmon AS Nerg(cid:134)rd AS Nils Williksen AS Nisja Trading AS Nor-Food AS Nordic Group ASA Nordreisa Laks AS Norexport AS Norfi Produkter AS Norfood Group AS Norfra Eksport AS Norsk Akvakultur AS Norsk Sjømat AS Northern Seafood AS Nortrade AS Norway Royal Salmon Sales AS Norway Royal Salmon AS Norway Seafoods ASA 8300 8302 8303 8304 8159 8428 8174 8177 8178 8179 8181 8182 8184 8185 8187 8188 8196 8197 8200 8202 8203 8206 8207 8210 8211 8213 8214 8217 8218 8223 8227 8228 8229 8232 8233 8307 8308 8309 8312 8314 L 123/24 FI Euroopan yhteis(cid:148)jen virallinen lehti 13. 5. 1999 Sitoumuksen numero Yrityksen nimi Taric-lis(cid:132)koodi 128 130 134 137 140 141 142 144 145 146 147 148 151 153 154 155 156 157 158 160 161 162 164 165 167 168 172 174 175 176 178 180 182 183 187 188 189 190 191 192 Norwell AS Nova Sea AS Ok-Fish Kvalheim AS Pan Fish Sales AS Polar Seafood Norway AS Prilam Norv(cid:138)ge AS Pundslett Fisk Rolf Olsen Seafood AS Ryfisk AS Rørvik Fisk- og fiskematforretning AS Saga Lax Norge AS Prima Nor AS Sangoltgruppa AS Scanfood AS Sea Eagle Group AS Sea Star International AS Sea-Bell AS Seaco AS Seacom AS Seafood Farmers of Norway Ltd AS Seanor AS Sekkingstad AS Sirena Norway AS Kinn Salmon AS SL Fjordgruppen AS SMP Marine Produkter AS Stjernelaks AS Stolt Sea Farm AS Storm Company AS Superior AS Terra Seafood AS Timar Seafood AS Torris Products Ltd AS Troll Salmon AS Vie de France Norway AS Vikenco AS Wannebo International AS West Fish Norwegian Salmon AS Nor-Fa Food AS Westmarine AS 8316 8235 8239 8242 8247 8248 8251 8254 8256 8257 8258 8259 8262 8264 8265 8266 8267 8268 8269 8271 8272 8273 8275 8276 8278 8279 8283 8285 8286 8287 8289 8294 8298 8317 8321 8322 8323 8324 8102 8625


title: 1999/325/EF: Rådets afgørelse af 10. maj 1999 om makrofinansiel bistand til Bosnien-Hercegovina

eurovoc_concepts:
Bosnia and Herzegovina
EU aid
financial aid

text: 13. 5. 1999 DA De Europæiske Fællesskabers Tidende L 123/57 R(cid:143)DETS AFGØRELSE af 10. maj 1999 om makrofinansiel bistand til Bosnien-Hercegovina (1999/325/EF) R(cid:143)DET FOR DEN EUROPÆISKE UNION HAR (cid:190) (6) under henvisning til Europæiske Fællesskab, særlig artikel 308, traktaten om oprettelse af Det under henvisning til forslag fra Kommissionen (1), Bosnien-Hercegovina har med Verdensbanken aftalt en række strukturtilpasningsforanstaltninger, der bakkes op af to særlig fordelagtige strukturtil- pasningsl(cid:134)n og -kreditter, der fokuserer p(cid:134) en reform af de offentlige finanser og privatisering af virksomheder og banker; under henvisning til udtalelse fra Europa-Parlamentet (2), og (7) ud fra følgende betragtninger: (1) (2) (3) (4) (5) Kommissionen har konsulteret Det Monetære Udvalg forud for fremsættelsen af sit forslag; iværksat fundamentale Bosnien-Hercegovina har institutionelle og politiske reformer for at etablere fælles institutioner og fastlægge fælles politikker; Bosnien-Hercegovina gør betydelige bestræbelser p(cid:134) dels at gennemføre økonomiske reformer, dels at indføre en (cid:134)ben markedsøkonomi, hvilket er væsentligt forbedre levevilk(cid:134)rene for befolkningen og muliggøre flygt- ningenes og den internt fordrevnes tilbagevenden; skabe arbejdspladser, for at inden for rammerne af den regionale strategi, som R(cid:134)det har defineret, er det ønskeligt at støtte bestræbelserne p(cid:134) at tilvejebringe et stabilt politisk og økonomisk klima i Bosnien-Hercegovina med henblik p(cid:134) at bidrage til udviklingen af fuldt udbyggede samarbejdsforbindelser med Fælles- skabet; den exceptionelle finansielle bistand fra Fælles- skabet bør bidrage til indførelsen af fælles instituti- oner og politikker i Bosnien-Hercegovina, der er i overensstemmelse med Dayton-fredsaftalen, og samtidig styrke den gensidige tillid og bringe Bosnien-Hercegovina tættere p(cid:134) Fællesskabet; institutionelle Bosnien-Hercegovina har med Den Internationale Valutafond (IMF) aftalt en lang række økonomiske som og tranche understøttes af et et(cid:134)rigt upper credit standby-arrangement; vil blive efterfulgt eller erstattet af en udvidet struktur- tilpasningsfacilitet (ESAF); reformforanstaltninger, standby-arrangementet (1) EFT C 396 af 19. 12. 1998, s. 16. (2) Udtalelse af 12. 3. 1999 (endnu ikke offentliggjort i EFT). (8) (9) (10) (11) Bosnien-Hercegovinas myndigheder har anmodet om bistand fra de internationale finansielle institu- tioner, Fællesskabet og andre bilaterale donorer; ud over det beløb, der skønnes at kunne tilvejebringes via IMF og Verdensbanken, vil der fortsat eksistere finansieringsgab, der skal dækkes i de et stort kommende m(cid:134)neder for at styrke landets reserve- stilling og støtte myndighedernes reformbestræ- belser; p(cid:134) den fjerde donorkonference for Bosnien-Herce- govina, der blev afholdt den 7. og 8. maj 1998, udtrykte det internationale samfund stor tilfredshed med de aftaler, der er indg(cid:134)et med Bretton Woods- institutionerne, og det besluttede at give sin fulde støtte til Bosnien-Hercegovinas økonomiske re- formprogram og genopbygningsprogram i form af faste tilsagn om finansiel bistand; finansielle myndighederne i Bosnien-Hercegovina har givet tilsagn om, at de i fuldt omfang vil opfylde alle de udest(cid:134)ende som alle landets offentlige enheder har over for Fællesskabet og Den Europæiske Investeringsbank, og at de i form af en garanti vil p(cid:134)tage sig ansvaret for de forpligtelser, der endnu ikke er forfaldne; forpligtelser, nærværende exceptionelle makrofinansielle bistand fra Fællesskabet til Bosnien-Hercegovina har til form(cid:134)l at lette landets finansielle bindinger over for udlandet, at støtte dets betalingsbalance og styrke dets reservestilling; da Bosnien-Hercegovina er et lavindkomstland, der er berettiget til særlig fordelagtige l(cid:134)n og faciliteter fra Verdensbanken og IMF, skal Fællesskabets makrofinansielle bistand ydes p(cid:134) særdeles favorable vilk(cid:134)r; L 123/58 DA De Europæiske Fællesskabers Tidende 13. 5. 1999 (12) en styrkelse af Bosnien-Hercegovinas fælles institu- tioner og en reform af landets økonomiske system er to af de prioriteter, der blev fastsat p(cid:134) fredsimple- menteringskonferencen i Madrid i december 1998; der er knyttet til Fællesskabets makrofinansielle bistand, med myndighederne i Bosnien-Hercegovina. Disse betin- gelser skal være i overensstemmelse med de aftaler, der er nævnt i artikel 1, stk. 4. (13) Den Europæiske Unions erklæring om Bosnien- Hercegovina af 8. juni 1998 anerkender, at frem- tiden for dette land ligger i Europa; indbygningen af et gaveelement i denne bistand berører ikke budgetmyndighedens beføjelser; Fællesskabets bistand bør forvaltes af Kommis- sionen; (14) (15) (16) regelmæssige 2. Kommissionen kontrollerer med mellemrum i samarbejde med Det Økonomiske og Finansielle Udvalg og i koordination med IMF, at den økonomiske og institutionelle politik i Bosnien-Hercego- vina er i overensstemmelse med m(cid:134)lene for den makrofi- nansielle bistand, og at betingelserne for bistanden over- holdes. traktaten indeholder ikke anden hjemmel til vedta- gelse af denne afgørelse end artikel 308 (cid:190) Artikel 3 TRUFFET FØLGENDE AFGØRELSE: Artikel 1 Fællesskabet stiller en exceptionel makrofinansiel 1. bistand til r(cid:134)dighed for Bosnien-Hercegovina i form af et langfristet l(cid:134)n og direkte gavebistand med henblik p(cid:134) at sikre en holdbar betalingsbalancesituation og styrke landets reservestilling. 2. L(cid:134)nebistanden best(cid:134)r af en hovedstol p(cid:134) maksimalt 20 mio. EUR med en afdragsfri periode p(cid:134) 10 (cid:134)r og en maksimal løbetid p(cid:134) 15 (cid:134)r. Til dette form(cid:134)l bemyndiges l(cid:134)ne de Kommissionen til p(cid:134) Fællesskabets vegne at nødvendige midler, som stilles til r(cid:134)dighed for Bosnien- Hercegovina i form af et l(cid:134)n. Gavebistanden udgør maksimalt 40 mio. EUR i 3. perioden 1999-2000. finansielle Fællesskabets 4. af Kommissionen i nært samr(cid:134)d med Det Økonomiske og Finansielle Udvalg og p(cid:134) en m(cid:134)de, der er i overensstem- melse med enhver aftale mellem IMF og Bosnien-Herce- govina. forvaltes bistand af, Bistanden er betinget at myndighederne i 5. Bosnien-Hercegovina i fuldt omfang opfylder alle offent- lige enheders udest(cid:134)ende og forfaldne finansielle forplig- telser over for Fællesskabet og Den Europæiske Investe- ringsbank, og at de i form af en garanti p(cid:134)tager sig ansvaret for de forpligtelser, der endnu ikke er forfaldne. Artikel 2 1. Kommissionen bemyndiges til, efter samr(cid:134)d med Det Økonomiske og Finansielle Udvalg, at aftale de betingelser for den økonomiske og institutionelle politik, L(cid:134)ne- og gavebistanden stilles 1. r(cid:134)dighed for Bosnien-Hercegovina i mindst to successive rater. Den første rate frigives, n(cid:134)r det er konstateret, at det et(cid:134)rige standby-arrangement mellem IMF og Bosnien-Hercego- vina er gennemført tilfredsstillende, jf. dog artikel 1, stk. 5, og artikel 2. til 2. Den anden rate frigives under forudsætning af en tilfredsstillende gennemførelse af IMF’s standby-arrange- ment og tidligst tre m(cid:134)neder efter frigivelsen af den første rate, jf. dog artikel 2. 3. Midlerne centralbank. udbetales til Bosnien-Hercegovinas Artikel 4 1. De l(cid:134)noptagelses- og l(cid:134)ngivningstransaktioner, der er nævnt i artikel 1, stk. 2, gennemføres med samme valørdato og m(cid:134) for Fællesskabet ikke medføre omlæg- ning af løbetider, valutakurs- og renterisici eller andre kommercielle risici. 2. Kommissionen skal, hvis Bosnien-Hercegovina ønsker det, sikre, at der indføjes en klausul om førtidig tilbagebetaling i l(cid:134)nebetingelserne og sikre, at en s(cid:134)dan klausul kan anvendes. 3. Giver omstændighederne mulighed for en forbed- ring af renten p(cid:134) l(cid:134)net, kan Kommissionen p(cid:134) Bosnien- Hercegovinas anmodning helt eller delvis rfefinansiere sine oprindelige l(cid:134)noptagelser eller omlægge de hertil svarende finansielle betingelser. En s(cid:134)dan refinansiering eller omlægning gennemføres p(cid:134) de betingelser, der er fastsat i stk. 1, og m(cid:134) ikke resultere i en forlængelse af den gennemsnitlige løbetid for de berørte l(cid:134)netransaktioner eller i en forhøjelse af restgælden, udtrykt i løbende valu- takurs, p(cid:134) datoen for disse transaktioner. 13. 5. 1999 DA De Europæiske Fællesskabers Tidende L 123/59 Bosnien-Hercegovina bærer alle de omkostninger, som Fællesskabet afholder i 4. forbindelse med indg(cid:134)else og gennemførelse af transaktioner i henhold til denne afgørelse. 5. Det Økonomiske og Finansielle Udvalg underrettes mindst (cid:130)n gang om (cid:134)ret om udviklingen i de transaktioner, der er omhandlet i stk. 2 og 3. Kommissionen tilsender mindst (cid:130)n gang om (cid:134)ret Europa-Parlamentet og R(cid:134)det en rapport indeholdende en vurdering af gennemførelsen af denne afgørelse. Artikel 5 Udfærdiget i Bruxelles, den 10. maj 1999. P(cid:134) R(cid:134)dets vegne H. EICHEL Formand


title: Σύμφωνη γνώμη αριθ. 2/99 που έδωσε το Συμβούλιο σύμφωνα με το άρθρο 95 της συνθήκης για την ίδρυση της Ευρωπαϊκής Κοινότητας A5Aνθρακα και Χάλυβα

eurovoc_concepts:
ECSC
Türkiye
joint committee (EU)
opinion
originating product

text: C 146/10 EL ¯(cid:240)(cid:223)(cid:243)(cid:231)(cid:236)(cid:231) ¯(cid:246)(cid:231)(cid:236)(cid:229)æ(cid:223)(cid:228)Æ (cid:244)ø(cid:237) ¯ıæø(cid:240)ÆœŒ(cid:254)(cid:237) ˚(cid:239)Ø(cid:237)(cid:239)(cid:244)(cid:222)(cid:244)ø(cid:237) 27. 5. 1999 (cid:201)(cid:201) (—æ(cid:239)(cid:240)ÆæÆ(cid:243)Œ(cid:229)ıÆ(cid:243)(cid:244)ØŒ(cid:221)(cid:242) (cid:240)æ(cid:220)(cid:238)(cid:229)Ø(cid:242)) (cid:211)(cid:213)(cid:204)´ˇ(cid:213)¸(cid:201)ˇ (cid:211)(cid:213)(cid:204)(cid:214)(cid:217)˝˙ ˆ˝(cid:217)(cid:204)˙ ÆæØŁ. 2/99 (cid:240)(cid:239)ı (cid:221)(cid:228)ø(cid:243)(cid:229) (cid:244)(cid:239) (cid:211)ı(cid:236)(cid:226)(cid:239)ı·ºØ(cid:239) (cid:243)ı·(cid:236)(cid:246)ø(cid:237)Æ (cid:236)(cid:229) (cid:244)(cid:239) (cid:220)æŁæ(cid:239) 95 (cid:244)(cid:231)(cid:242) (cid:243)ı(cid:237)Ł(cid:222)Œ(cid:231)(cid:242) ªØÆ (cid:244)(cid:231)(cid:237) (cid:223)(cid:228)æı(cid:243)(cid:231) (cid:244)(cid:231)(cid:242) ¯ıæø(cid:240)ÆœŒ(cid:222)(cid:242) ˚(cid:239)Ø(cid:237)(cid:252)(cid:244)(cid:231)(cid:244)Æ(cid:242) ¢(cid:237)ŁæÆŒÆ ŒÆØ (cid:215)(cid:220)ºı(cid:226)Æ (1999/C 146/10) …(cid:240)ø(cid:242) (cid:230)(cid:222)(cid:244)(cid:231)(cid:243)(cid:229) (cid:231) ¯(cid:240)Ø(cid:244)æ(cid:239)(cid:240)(cid:222), (cid:244)(cid:239) (cid:211)ı(cid:236)(cid:226)(cid:239)ı·ºØ(cid:239) (cid:221)(cid:228)ø(cid:243)(cid:229), (cid:243)(cid:244)Ø(cid:242) 10 (cid:204)Æ(cid:192)(cid:239)ı 1999, (cid:244)(cid:231) (cid:243)ı·(cid:236)(cid:246)ø(cid:237)(cid:231) ª(cid:237)(cid:254)(cid:236)(cid:231) (cid:244)(cid:239)ı (cid:243)(cid:247)(cid:229)(cid:244)ØŒ(cid:220) (cid:236)(cid:229) (cid:244)(cid:239) (cid:243)(cid:247)(cid:221)(cid:228)Ø(cid:239) Æ(cid:240)(cid:252)(cid:246)Æ(cid:243)(cid:231)(cid:242) (cid:244)(cid:231)(cid:242) ¯(cid:240)Ø(cid:244)æ(cid:239)(cid:240)(cid:222)(cid:242) ªØÆ (cid:244)(cid:231) Ł(cid:221)(cid:243)(cid:231) (cid:240)(cid:239)ı ŁÆ º(cid:220)(cid:226)(cid:229)Ø (cid:231) ¯ıæø(cid:240)ÆœŒ(cid:222) ˚(cid:239)Ø(cid:237)(cid:252)(cid:244)(cid:231)(cid:244)Æ ¢(cid:237)ŁæÆŒÆ ŒÆØ (cid:215)(cid:220)ºı(cid:226)Æ (cid:243)(cid:244)(cid:239) (cid:240)ºÆ(cid:223)(cid:243)Ø(cid:239) (cid:244)(cid:231)(cid:242) (cid:204)ØŒ(cid:244)(cid:222)(cid:242) ¯(cid:240)Ø(cid:244)æ(cid:239)(cid:240)(cid:222)(cid:242) (cid:240)(cid:239)ı (cid:243)ı(cid:243)(cid:244)(cid:220)Ł(cid:231)Œ(cid:229) (cid:236)(cid:229) (cid:244)(cid:231) (cid:243)ı(cid:236)(cid:246)ø(cid:237)(cid:223)Æ (cid:236)(cid:229)(cid:244)Æ(cid:238)ı· (cid:244)(cid:231)(cid:242) ¯ıæø(cid:240)ÆœŒ(cid:222)(cid:242) ˚(cid:239)Ø(cid:237)(cid:252)(cid:244)(cid:231)(cid:244)Æ(cid:242) ¢(cid:237)ŁæÆŒÆ ŒÆØ (cid:215)(cid:220)ºı(cid:226)Æ ŒÆØ (cid:244)(cid:231)(cid:242) (cid:212)(cid:239)ıæŒ(cid:223)Æ(cid:242) ªØÆ (cid:244)Ø(cid:242) (cid:243)ı(cid:237)ÆººÆª(cid:221)(cid:242) (cid:243)(cid:244)(cid:239)(cid:237) (cid:244)(cid:239)(cid:236)(cid:221)Æ (cid:244)ø(cid:237) (cid:240)æ(cid:239)œ(cid:252)(cid:237)(cid:244)ø(cid:237) (cid:240)(cid:239)ı ŒÆºı·(cid:240)(cid:244)(cid:239)(cid:237)(cid:244)ÆØ Æ(cid:240)(cid:252) (cid:244)(cid:231) (cid:243)ı(cid:237)Ł(cid:222)Œ(cid:231) ªØÆ (cid:244)(cid:231)(cid:237) (cid:223)(cid:228)æı(cid:243)(cid:231) (cid:244)(cid:231)(cid:242) ¯ıæø(cid:240)ÆœŒ(cid:222)(cid:242) ˚(cid:239)Ø(cid:237)(cid:252)(cid:244)(cid:231)(cid:244)Æ(cid:242) ¢(cid:237)ŁæÆŒÆ ŒÆØ (cid:215)(cid:220)ºı(cid:226)Æ, (cid:252)(cid:243)(cid:239)(cid:237) Æ(cid:246)(cid:239)æ(cid:220) (cid:244)(cid:231)(cid:237) (cid:244)æ(cid:239)(cid:240)(cid:239)(cid:240)(cid:239)(cid:223)(cid:231)(cid:243)(cid:231) (cid:244)(cid:239)ı (cid:240)æø(cid:244)(cid:239)Œ(cid:252)ºº(cid:239)ı ÆæØŁ. 1 ªØÆ (cid:244)(cid:239)ı(cid:242) ŒÆ(cid:237)(cid:252)(cid:237)(cid:229)(cid:242) ŒÆ(cid:244)Æªøª(cid:222)(cid:242). ˆØÆ (cid:244)(cid:239) (cid:211)ı(cid:236)(cid:226)(cid:239)ı·ºØ(cid:239) ˇ —æ(cid:252)(cid:229)(cid:228)æ(cid:239)(cid:242) ˙. EICHEL


title: Eiropas Parlamenta un Padomes Direktīva 1999/34/EK (1999. gada 10. maijs), ar ko groza Padomes Direktīvu 85/374/EEK par dalībvalstu normatīvo un administratīvo aktu tuvināšanu attiecībā uz atbildību par produktiem ar trūkumiem

eurovoc_concepts:
defective product
electrical energy
indemnification
personal property
producer's liability

text: 15/4. sēj. LV Eiropas Savienības Oficiālais Vēstnesis 147 31999L0034 L 141/20 EIROPAS KOPIENU OFICIĀLAIS VĒSTNESIS 4. 6. 1999. EIROPAS PARLAMENTA UN PADOMES DIREKTĪVA 1999/34/EK (1999. gada 10. maijs), ar ko groza Padomes Direktīvu 85/374/EEK par dalībvalstu normatīvo un administratīvo aktu tuvināšanu attiecībā uz atbildību par produktiem ar trūkumiem EIROPAS PARLAMENTS UN EIROPAS SAVIENĪBAS PADOME, (4) ņemot vērā Eiropas Kopienas dibināšanas līgumu, un jo īpaši tā 95. pantu, ņemot vērā Komisijas priekšlikumu (1), tā kā Komisija pārrauga Direktīvas 85/374/EEK īstenošanu un ietekmi, un jo īpaši tās aspektu par patērētāju aizsar- dzību un iekšējā tirgus darbību attiecībā uz pirmo ziņo- jumu; tā kā šajā sakarā Komisijai saskaņā ar minētās direk- tīvas 21. pantu jāiesniedz otrs ziņojums par tās piemērošanu; ņemot vērā Ekonomikas un sociālo lietu komitejas atzinumu (2), saskaņā ar Līguma 251. pantā noteikto procedūru (3), (5) tā kā lauksaimniecības pamatproduktu iekļaušana Direktī- vas 85/374/EEK piemērošanas jomā palīdzētu atjaunot patērētāju uzticību lauksaimniecības produktu drošībai; tā kā šāds pasākums atbilstu augsta līmeņa patērētāju aizsar- dzības prasībām; (1) (2) tā kā produkta drošība un atlīdzība par kaitējumu, ko izrai- sījuši produkti ar trūkumiem, ir obligātas sociālās prasības, kuras jāievēro iekšējā tirgū; tā kā Kopiena šīs prasības ir nodrošinājusi ar Direktīvu 85/374/EEK (4) un Padomes Direktīvu 92/59/EEK (1992. gada 29. jūnijs) par produktu vispārēju drošību (5); tā kā ar Direktīvu 85/374/EEK izveidoja taisnīgu tādu risku sadali, kas ir raksturīgi mūsdienu sabiedrībā, kurā ir augsta tehnisko īpatnību pakāpe; tā kā minētā direktīva tādēļ sas- niedza saprātīgu līdzsvaru starp iesaistītajām interesēm, jo īpaši starp patērētāju veselības aizsardzību, jauninājumu, zinātniskās un tehnoloģiskās attīstības veicināšanu, garan- tējot netraucētu konkurenci un veicinot tirdzniecību saska- ņotā civiltiesiskās atbildības sistēmā; tā kā minētā direktīva tādējādi ir palīdzējusi veicināt tirgotāju izpratni par pro- duktu drošību un tai pievērsto nozīmīgumu; (3) tā kā dalībvalstu tiesību aktu saskaņošanas pakāpe, kas sas- niegta ar Direktīvu 85/374/EEK, nav pilnīga saistībā ar paredzētajām atkāpēm, jo īpaši attiecībā uz direktīvas apjomu, no kura izslēgti nepārstrādāti lauksaimniecības produkti; (1) OV C 337, 7. 11. 1997. , 54. lpp. (2) OV C 95, 30. 3. 1998. , 69. lpp. (3) Eiropas Parlamenta 1998. gada 5. novembra Atzinums (OV C 359, 23. 11. 1998. , 25. lpp. ), Padomes 1998. gada 17. decembra Kopējā nostāja (OV C 49, 22. 2. 1999. , 1. lpp. ) un Eiropas Parlamenta 1999. gada 23. marta Lēmums (Oficiālajā Vēstnesī vēl nav publicēts). Padomes 1999. gada 29. aprīļa Lēmums. (4) OV L 210, 7. 8. 1985. , 29. lpp. Direktīva grozīta ar 1994. gada Pie- vienošanās aktu. (5) OV L 228, 11. 8. 1992. , 24. lpp. (6) tā kā apstākļi pieprasa grozīt Direktīvu 85/374/EEK, lai patērētāju labad veicinātu likumīgu atlīdzību par kaitējumu veselībai, ko izraisījuši lauksaimniecības produkti ar trūku- miem; (7) tā kā šī direktīva ietekmē iekšējā tirgus darbību, jo tirdz- niecību ar lauksaimniecības produktiem vairāk neietekmēs atšķirības noteikumos par ražotāja atbildību; (8) (9) tā kā atbildība bez vainas, kas noteikta Direktīvā 85/374/EEK, jāpiemēro visiem produktu veidiem, tostarp lauksaimniecības produktiem, Līguma 32. panta 1. punkta otrajā teikumā un uzskaitīti minētā Līguma I pielikumā; definēti kas tā kā saskaņā ar proporcionalitātes principu ir nepiecie- šams un lietderīgi iekļaut lauksaimniecības produktus Direktīvas 85/374/EEK piemērošanas jomā, lai sasniegtu visu patērētāju paaugstinātas aizsardzības un pareizas iek- šējā tirgus darbības pamatmērķus; tā kā šī direktīva apro- bežojas ar to, kas nepieciešams, lai sasniegtu izvirzītos mērķus saskaņā ar Līguma 5. panta trešo daļu, 148 LV Eiropas Savienības Oficiālais Vēstnesis 15/4. sēj. IR PIEŅĒMUŠI ŠO DIREKTĪVU. 1. pants Direktīvu 85/374/EEK groza šādi. 1. Direktīvas 2. pantu aizstāj ar šādu pantu: “2. pants Šajā direktīvā “produkts” nozīmē visas kustamas lietas, pat ja tās ir izmantotas kādā citā kustamā lietā vai nekustamā īpašumā. Pie “produktiem” pieder elektrība. ” 2. Direktīvas 15. panta 1. punkta a) apakšpunktu svītro. Kad dalībvalstis pieņem šādus tiesību aktus, tajos iekļauj atsauci uz šo direktīvu vai arī šādu atsauci pievieno to oficiālai publikā- cijai. Dalībvalstis nosaka paņēmienus, kā izdarīt šādas atsauces. 2. Dalībvalstis dara Komisijai zināmus to tiesību aktu noteiku- mus, ko tās turpmāk pieņem jomā, uz kuru attiecas šī direktīva. 3. pants Šī direktīva stājas spēkā dienā, kad to publicē Eiropas Kopienu Oficiālajā Vēstnesī. Šī direktīva ir adresēta dalībvalstīm. 4. pants 2. pants Briselē, 1999. gada 10. maijā 1. Dalībvalstis pieņem un publicē normatīvos un administratīvos aktus, kas vajadzīgi, lai izpildītu šīs direktīvas prasības. Dalībval- stis par to tūlīt informē Komisiju. Tās piemēro minētos pasākumus no 2000. gada 4. decembra. Eiropas Parlamenta vārdā — Padomes vārdā — priekšsēdētājs J. M. GIL-ROBLES priekšsēdētājs H. EICHEL


title: Council Regulation (EC) No 1003/1999 of 10 May 1999 amending Regulation (EC) No 772/1999 imposing definitive anti-dumping and countervailing duties on imports of farmed Atlantic salmon originating in Norway

text: 13. 5. 1999 EN Official Journal of the European Communities L 123/19 COUNCIL REGULATION (EC) No 1003/1999 of 10 May 1999 amending Regulation (EC) No 772/1999 imposing definitive anti-dumping and countervailing duties on imports of farmed Atlantic salmon originating in Norway THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Treaty establishing the European Community, report at all and two Norwegian exporters appeared to have sold the product concerned to the Community market at a price which was below the price provided for in their undertakings. Having regard to Council Regulation (EC) No 384/96 of 22 December 1995 on protection against dumped imports from countries the European Community (1), and in particular Articles 8(9) and 9 thereof, not members of Having regard to Council Regulation (EC) No 2026/97 of 6 October 1997 on protection against subsidised imports the European from countries Community (2), and in particular Articles 13(9) and 15 thereof, not members of Having regard to the proposal submitted by the Commis- sion after consulting the Advisory Committee, Whereas: A. PROVISIONAL DUTIES (1) Within the framework of the anti-dumping and anti-subsidy investigations initiated by two separate notices published in the Official Journal of the the Commission European accepted, by Decision 97/634/EC (4), undertakings offered by the Kingdom of Norway and by 190 Norwegian exporters. Communities (3), (2) The text of the undertakings provides that failure to submit a quaterly report of all sales transactions to the first unrelated customer in the Community within a prescribed time-limit except in case of force majeure would be construed as a violation of the undertaking, as would non-compliance with the obligation to sell the product concerned on the Community market at or above the minimum prices provided for in the undertaking. (3) For the second quarter of 1998, 10 Norwegian companies either did not present a report within the prescribed time limit (or did not submit any (1) OJ L 56, 6. 3. 1996, p. 1; Regulation as last amended by Regu- lation (EC) No 905/98 (OJ L 128, 30. 4. 1998, p. 18). (2) OJ L 288, 21. 10. 1997, p. 1. (3) OJ C 235, 31. 8. 1996, p. 18 and OJ C 235, 31. 8. 1996, p. 20. (4) OJ L 267, 30. 9. 1997, p. 81; Decision as last amended by Regulation (EC) No 2249/98 (OJ L 282, 20. 10. 1998, p. 57). (4) (5) (6) The Commission therefore had reason to believe that these 12 companies had breached the terms of their undertakings. Consequently, the Commission, by Regulation (EC) No 82/1999 (5) hereinafter referred to as the ‘Provi- sional Duty Regulation', imposed provisional anti- dumping and countervailing duties on imports of farmed Atlantic salmon falling within CN codes ex 0302 12 00, ex 0304 10 13, ex 0303 22 00 and ex 0304 20 13 originating in Norway and exported by the six (initially 12) companies listed in the Annex to that Regulation. By the same Regulation, the Commission deleted the companies concerned from the Annex to Decision 97/634/EC, which listed the companies from which undertakings were accepted. B. SUBSEQUENT PROCEDURE duties received All 12 Norwegian companies subject to the provi- sional in writing concerning the essential facts and considerations, on the basis of which these provisional duties were imposed. They were also given an opportunity to submit comments and request a hearing. disclosure (7) Within the time limit set in the provisional duty the Norwegian companies Regulation, nine of concerned submitted comments in writing and five requested hearings, which were granted. In addi- tion, comments were also submitted by the Norwe- gian Seafood Association on behalf of two of the to the provisional measures. companies subject Following these submissions, the Commission sought and examined all information it deemed necessary for the purpose of a definitive deter- mination on the apparent violations. (5) OJ No L 8, 14. 1. 1999, p. 8; Regulation as last amended by Regulation (EC) No 929/1999 (OJ L 115, 4. 5. 1999, p. 13). L 123/20 EN Official Journal of the European Communities 13. 5. 1999 (8) regard, the Commission’s investigation In this established that six of the companies against which provisional measures had been imposed had not violated their undertakings and that they should be reinstated on the list of companies benefiting from an exemption from the anti-dumping and counter- vailing measures. These exporters were informed of the essential facts and considerations on the basis of which it was intended to reinstate the Commis- sion’s acceptance of their undertakings. As concerns the other six companies subject to provisional measures, they were informed of the essential facts and considerations on the basis of which it was intended to confirm the withdrawal of the Commission’s acceptance of their undertaking and to recommend the imposition of definitive anti-dumping and countervailing duties and the definitive collection of the amounts secured by way of provisional duties. They were also granted a period within which to make representations subsequent to this disclosure. (9) The Commission’s findings in this respect are set out more fully in Regulation (EC) No 929/1999. conclusion that definitive (10) None of the comments submitted, however, have anti- changed the dumping and countervailing duties should be imposed on imports of farmed Atlantic salmon originating in Norway and exported by the six companies listed in Annex I to this Regulation. C. DEFINITIVE DUTIES (11) (12) The investigations which led to the undertakings were concluded by a final determination as to dumping and injury by Regulation (EC) No 1890/ 97 (1) and by a final determination as to subsidisa- tion and injury by Regulation (EC) No 1891/97 (2). In accordance with Article 8(10) of Regulation (EC) No 384/96 and Article 13(10) of Regulation (EC) No 2067/97 respectively, the anti- dumping duty and the countervailing duty must be established on the basis of the best information available. the rate of (13) In this regard, and in view of recital 107 of Regula- tion (EC) No 1890/97 and recital 149 of Regulation (EC) No 1891/97, it is considered appropriate that the definitive anti-dumping and countervailing (1) OJ L 267, 30. 9. 1997, p. 1; Regulation as last amended by Regulation (EC) No 2052/98 (OJ L 264, 29. 9. 1998, p. 17). (2) OJ L 267, 30. 9. 1997, p. 19; Regulation as last amended by Regulation (EC) No 2052/98 (OJ L 264, 29. 9. 1998, p. 17). duty rates be set at the level and in the form imposed by Regulation (EC) No 772/1999 (3). D. DEFINITIVE COLLECTION OF PROVI- SIONAL DUTIES (14) A breach of undertaking has been established in relation to six exporters which have violated their undertakings. Therefore, it is considered necessary that, in relation to these exporters, the amounts secured by way of provisional anti-dumping and countervailing duties be definitively collected at the level of the definitive duties. E. AMENDMENT OF THE ANNEX TO REGULA- TION (EC) No 772/1999 (15) Two Norwegian companies, Saga Lax Nord AS and Hydro Seafood Sales AS, which are on the list of companies from which undertakings are accepted, informed the Commission that their names had changed to Prima Nor AS and Hydro Seafood Norway AS respectively. They requested that these changes be reflected in the list of companies bene- fiting from the exemption from payment of anti- dumping and countervailing duties. The Commis- sion has verified that there were no changes in their corporate structures which would call for a more detailed examination of the appropriateness of them maintaining their undertakings. (16) Accordingly, in view of all the above, the Annex to Regulation (EC) No 772/1999 exempting the parties listed therein from the duty, should be amended so as to remove the exemption from the companies listed in Annex I hereto. The said Annex should also be amended to take account of the change of name to Prima Nor AS by the company Saga Lax Nord AS and the change of name to Hydro Seafood Norway AS by the company Hydro Seafood Sales AS, HAS ADOPTED THIS REGULATION: Article 1 The Annex to Regulation (EC) No 772/1999 shall be replaced by Annex II to this Regulation. (3) OJ L 101, 16. 4. 1999, p. 1. 13. 5. 1999 EN Official Journal of the European Communities L 123/21 Article 2 The amounts secured by way of the provisional anti-dumping and countervailing duties imposed by Regulation (EC) No 82/1999 in relation to farmed (other than wild) Atlantic salmon falling within CN codes ex 0302 12 00 (TARIC code: 0302 12 00*19), ex 0304 10 13 (TARIC code: 0304 10 13*19), ex 0303 22 00 (TARIC code: 0303 22 00*19) and ex 0304 20 13 (TARIC code: 0304 20 13*19) originating in Norway and exported by the companies listed in Annex I to this Regulation shall be definitively collected. This Regulation shall enter into force on the day following its publication in the Official Journal of the European Communities. Article 3 This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 10 May 1999. For the Council The President H. EICHEL ANNEX I List of companies subject to definitive anti-dumping and countervailing duties No VT Company TARIC additional code 1 5 30 65 159 171 A. Ovrekotnes AS Alsvag Fiskeprodukter A/S Brødrene Remo A/S Hitramat & Delikatesse AS Seacom Nord AS Stavanger Røkeri AS 8095 8098 8128 8154 8270 8282 L 123/22 EN Official Journal of the European Communities 13. 5. 1999 ANNEX II List of companies exempted from the definitive anti-dumping and countervailing duties UT No Company TARIC additional code 3 7 8 11 13 14 15 16 17 20 21 22 23 24 26 27 28 31 32 33 35 36 39 41 42 43 44 46 47 48 50 51 52 53 Agnefest Seafood Aqua Export A/S Aqua Partner A/S Arctic Group International Artic Superior A/S Arne Mathiesen A/S A/S Aalesundfisk A/S Austevoll Fiskeindustri A/S Keco A/S Refsnes Fiskeindustri A/S West Fish Ltd Astor A/S Atlantic King Stranda A/S Atlantic Seafood A/S Borkowski & Rosnes A/S Brødrene Aasjord A/S Brødrene Eilertsen A/S Christiansen Partner A/S Clipper Seafood A/S Coast Seafood A/S Dafjord Laks A/S Delfa Norge A/S Domstein Salmon A/S Ecco Fisk & Delikatesse Edvard Johnsen A/S Eurolaks AS Euronor AS Fiskeforsyningen AS Fjord Aqua Group AS Fjord Trading Ltd AS Fossen AS Fresh Atlantic AS Fresh Marine Company AS Fryseriet AS 8325 8100 8101 8109 8111 8112 8113 8114 8115 8118 8119 8120 8121 8122 8124 8125 8126 8129 8130 8131 8133 8134 8136 8138 8139 8140 8141 8143 8144 8145 8147 8148 8149 8150 13. 5. 1999 EN Official Journal of the European Communities L 123/23 UT No Company TARIC additional code 58 60 61 62 66 67 72 75 76 77 79 80 82 83 85 87 92 93 96 98 99 100 101 104 105 107 108 111 112 113 114 115 116 119 120 121 122 123 124 126 Grieg Seafood AS Haafa fisk AS Hallvard Lerøy AS Herøy Filetfabrikk AS Hydro Seafood Norway AS Hydrotech-gruppen AS Inter Sea AS Janas AS Joh. H. Pettersen AS Johan J. Helland AS Karsten J. Ellingsen AS Kr. Kleiven & Co. AS Labeyrie Norge AS Lafjord Group AS Leica Fiskeprodukter Lofoten Seafood Export AS Marine Seafood AS Marstein Seafood AS Memo Food AS Midsundfisk AS Myre Sjømat AS Naco Trading AS Namdal Salmon AS Nerg(cid:134)rd AS Nils Williksen AS Nisja Trading AS Nor-Food AS Nordic Group ASA Nordreisa Laks AS Norexport AS Norfi Produkter AS Norfood Group AS Norfra Eksport AS Norsk Akvakultur AS Norsk Sjømat AS Northern Seafood AS Nortrade AS Norway Royal Salmon Sales AS Norway Royal Salmon AS Norway Seafoods ASA 8300 8302 8303 8304 8159 8428 8174 8177 8178 8179 8181 8182 8184 8185 8187 8188 8196 8197 8200 8202 8203 8206 8207 8210 8211 8213 8214 8217 8218 8223 8227 8228 8229 8232 8233 8307 8308 8309 8312 8314 L 123/24 EN Official Journal of the European Communities 13. 5. 1999 UT No Company TARIC additional code 128 130 134 137 140 141 142 144 145 146 147 148 151 153 154 155 156 157 158 160 161 162 164 165 167 168 172 174 175 176 178 180 182 183 187 188 189 190 191 192 Norwell AS Nova Sea AS Ok-Fish Kvalheim AS Pan Fish Sales AS Polar Seafood Norway AS Prilam Norv(cid:138)ge AS Pundslett Fisk Rolf Olsen Seafood AS Ryfisk AS Rørvik Fisk- og fiskematforretning AS Saga Lax Norge AS Prima Nor AS Sangoltgruppa AS Scanfood AS Sea Eagle Group AS Sea Star International AS Sea-Bell AS Seaco AS Seacom AS Seafood Farmers of Norway Ltd AS Seanor AS Sekkingstad AS Sirena Norway AS Kinn Salmon AS SL Fjordgruppen AS SMP Marine Produkter AS Stjernelaks AS Stolt Sea Farm AS Storm Company AS Superior AS Terra Seafood AS Timar Seafood AS Torris Products Ltd AS Troll Salmon AS Vie de France Norway AS Vikenco AS Wannebo International AS West Fish Norwegian Salmon AS Nor-Fa Food AS Westmarine AS 8316 8235 8239 8242 8247 8248 8251 8254 8256 8257 8258 8259 8262 8264 8265 8266 8267 8268 8269 8271 8272 8273 8275 8276 8278 8279 8283 8285 8286 8287 8289 8294 8298 8317 8321 8322 8323 8324 8102 8625


title: 1999/341/ΕΚ: Απόφαση του Συμβουλίου, της 10ης Μαΐου 1999, για τη σύναψη της συμφωνίας υπό μορφή ανταλλαγής επιστολών σχετικά με την προσωρινή εφαρμογή του πρωτοκόλλου που καθορίζει, για την περίοδο από 18 Ιανουαρίου 1999 έως 17 Ιανουαρίου 2002, τις αλιευτικές δυνατότητες και τη χρηματοδοτική αντιστάθμιση που προβλέπονται στη συμφωνία μεταξύ της Ευρωπαϊκής Οικονομικής Κοινότητας και της Δημοκρατίας των Σεϋχελλών, για την αλιεία στα ανοικτά των Σεϋχελλών

eurovoc_concepts:
Seychelles
agreement (EU)
financial compensation of an agreement
fishing agreement
fishing rights
protocol to an agreement

text: L 131/50 EL Ep(cid:148)sglg Evgleq(cid:148)da tym Euqypa(cid:152)j(cid:150)m Joimot(cid:147)tym 27. 5. 1999 II (Pq(cid:145)neir cia tgm isw(cid:151) tym opo(cid:148)ym dem apaite(cid:148)tai dglos(cid:148)eusg) SULBOUKIO APOVASG TOU SULBOUKIOU tgr 10gr La(cid:155)ou 1999 cia tg s(cid:151)maxg tgr sulvym(cid:148)ar up(cid:149) loqv(cid:147) amtakkac(cid:147)r epistok(cid:150)m swetij(cid:145) le tgm pqosyqim(cid:147) evaqloc(cid:147) tou pqytoj(cid:149)kkou pou jahoq(cid:148)fei, cia tgm peq(cid:148)odo ap(cid:149) 18 Iamouaq(cid:148)ou 1999 (cid:146)yr 17 Iamouaq(cid:148)ou 2002, tir akieutij(cid:146)r dumat(cid:149)tgter jai tg wqglatodotij(cid:147) amtist(cid:145)hlisg pou pqobk(cid:146)- pomtai stg sulvym(cid:148)a letan(cid:151) tgr Euqypa(cid:152)j(cid:147)r Oijomolij(cid:147)r Joim(cid:149)tgtar jai tgr Dglojqat(cid:148)ar tym Se(cid:153)wekk(cid:150)m, cia tgm akie(cid:148)a sta amoijt(cid:145) tym Se(cid:153)wekk(cid:150)m (1999/341/EJ) TO SULBOUKIO TGS EUQYPA(cid:136)JGS EMYSGS, (cid:130)womtar up(cid:149)xg: tg sumh(cid:147)jg cia tgm (cid:148)dqusg tgr Euqypa(cid:152)j(cid:147)r Joim(cid:149)tgtar, (4) tg sulvym(cid:148)a letan(cid:151) tgr Euqypa(cid:152)j(cid:147)r Oijomolij(cid:147)r Joim(cid:149)tg- tar jai tgr Dglojqat(cid:148)ar tym Se(cid:153)wekk(cid:150)m cia tgm akie(cid:148)a sta amoijt(cid:145) tym Se(cid:153)wekk(cid:150)m (1), pou upocq(cid:145)vgje stir Bqun(cid:146)kker stir 28 Ojtybq(cid:148)ou 1987, jai id(cid:148)yr to (cid:145)qhqo 12, tgm pq(cid:149)tasg tgr Epitqop(cid:147)r, Ejtil(cid:150)mtar: (1) (2) (3) (cid:149)ti g Joim(cid:149)tgta jai g Dglojqat(cid:148)a tym Se(cid:153)wekk(cid:150)m pqo(cid:146)bgsam se diapqaclate(cid:151)seir cia ma jahoq(cid:148)soum tir tqopopoi(cid:147)seir pou pq(cid:146)pei ma c(cid:148)moum stgm em k(cid:149)cy sulvym(cid:148)a sto t(cid:146)kor tgr peqi(cid:149)dou evaqloc(cid:147)r tou isw(cid:151)omtor pqytoj(cid:149)kkou, to opo(cid:148)o pqosaqt(cid:145)tai s’ aut(cid:147)· (cid:149)ti stg sum(cid:146)weia aut(cid:150)m tym diapqaclate(cid:151)seym, (cid:146)ma m(cid:146)o pqyt(cid:149)jokko lomocqav(cid:147)hgje, stir 21 Dejelbq(cid:148)ou 1998, b(cid:145)sei tou opo(cid:148)ou oi akie(cid:148)r tgr Joim(cid:149)tgtar apoka(cid:151)oum akieutij(cid:150)m dumatot(cid:147)tym sta (cid:151)data pou up(cid:145)comtai stgm juqiaqw(cid:148)a (cid:147) tg dijaiodos(cid:148)a tgr Dglojqat(cid:148)ar tym Se(cid:153)wekk(cid:150)m, cia tgm peq(cid:148)odo ap(cid:149) 18 Iamouaq(cid:148)ou 1999 (cid:146)yr 17 Iamouaq(cid:148)ou 2002· (cid:149)ti, cia ma apoveuwhe(cid:148) diajop(cid:147) tym akieutij(cid:150)m dqastgqiot(cid:147)tym tym sjav(cid:150)m tgr Joim(cid:149)tgtar, ta d(cid:151)o l(cid:146)qg lom(cid:149)cqaxam sulvym(cid:148)a up(cid:149) loqv(cid:147) amtakkac(cid:147)r (1) EE L 119 tgr 7. 5. 1987, s. 26. epistok(cid:150)m pou pqobk(cid:146)pei tgm pqosyqim(cid:147) evaqloc(cid:147) tou em k(cid:149)cy pqytoj(cid:149)kkou, ap(cid:149) tgm ep(cid:149)lemg gl(cid:146)qa tgr gleqolgm(cid:148)ar k(cid:147)ngr tou isw(cid:151)omtor pqytoj(cid:149)kkou· (cid:149)ti sumtq(cid:146)wei k(cid:149)cor ma ecjqihe(cid:148) g sulvym(cid:148)a up(cid:149) loqv(cid:147) amtakkac(cid:147)r epistok(cid:150)m, le tgm epiv(cid:151)kang oqistij(cid:147)r ap(cid:149)vasgr le b(cid:145)sg to (cid:145)qhqo 43 tgr sumh(cid:147)jgr· (5) (cid:149)ti epib(cid:145)kketai ma jahoqiste(cid:148) g l(cid:146)hodor jatamol(cid:147)r tym akieutij(cid:150)m dumatot(cid:147)tym letan(cid:151) tym jqat(cid:150)m lek(cid:150)m le b(cid:145)sg tgm paqadosiaj(cid:147) jatamol(cid:147) tym akieutij(cid:150)m dumatot(cid:147)tym sto pka(cid:148)sio tgr akieutij(cid:147)r sulvym(cid:148)ar, APOVASIFEI: (cid:129)qhqo 1 G sulvym(cid:148)a up(cid:149) loqv(cid:147) amtakkac(cid:147)r epistok(cid:150)m cia tgm pqosyqim(cid:147) evaqloc(cid:147) tou pqytoj(cid:149)kkou pou jahoq(cid:148)fei, cia tgm peq(cid:148)odo ap(cid:149) 18 Iamouaq(cid:148)ou 1999 (cid:146)yr 17 Iamouaq(cid:148)ou 2002, tir akieutij(cid:146)r dumat(cid:149)tgter jai tg wqglatodotij(cid:147) amtist(cid:145)hlisg pou pqobk(cid:146)pomtai stg sulvym(cid:148)a letan(cid:151) tgr Euqypa(cid:152)j(cid:147)r Oijomolij(cid:147)r Joim(cid:149)tgtar jai tgr Dglojqat(cid:148)ar tym Se(cid:153)wekk(cid:150)m, cia tgm akie(cid:148)a sta amoijt(cid:145) tym Se(cid:153)wekk(cid:150)m, ecjq(cid:148)metai en om(cid:149)lator tgr Euqypa(cid:152)j(cid:147)r Joim(cid:149)tgtar. Ta je(cid:148)lema tgr sulvym(cid:148)ar up(cid:149) loqv(cid:147) amtakkac(cid:147)r epi- stok(cid:150)m episum(cid:145)ptomtai stgm tou paqo(cid:151)sa ap(cid:149)vasg. pqytoj(cid:149)kkou jai 27. 5. 1999 EL Ep(cid:148)sglg Evgleq(cid:148)da tym Euqypa(cid:152)j(cid:150)m Joimot(cid:147)tym L 131/51 (cid:129)qhqo 2 Oi akieutij(cid:146)r dumat(cid:149)tgter pou jahoq(cid:148)fomtai sto pqyt(cid:149)jok- ko jatam(cid:146)lomtai letan(cid:151) tym jqat(cid:150)m lek(cid:150)m le tgm aj(cid:149)kou- hg l(cid:146)hodo: a) hummakieutij(cid:145) cqi cqi: (cid:190) Ispam(cid:148)a: 25 sj(cid:145)vg (cid:190) Cakk(cid:148)a: 20 sj(cid:145)vg (cid:190) Itak(cid:148)a: 1 sj(cid:145)vor (cid:190) Gmyl(cid:146)mo Bas(cid:148)keio: 1 sj(cid:145)vor b) paqacadi(cid:145)qija epivame(cid:148)ar: (cid:190) Ispam(cid:148)a: 20 sj(cid:145)vg (cid:190) Cakk(cid:148)a: 5 sj(cid:145)vg (cid:190) Poqtocak(cid:148)a: 7 sj(cid:145)vg E(cid:145)m oi ait(cid:147)seir adei(cid:150)m aut(cid:150)m tym jqat(cid:150)m lek(cid:150)m dem enamtk(cid:147)soum tir akieutij(cid:146)r dumat(cid:149)tgter pou jahoq(cid:148)fomtai sto pqyt(cid:149)jokko, g Epitqop(cid:147) lpoqe(cid:148) ma k(cid:145)bei up(cid:149)xg tir ait(cid:147)seir adei(cid:150)m opoioud(cid:147)pote (cid:145)kkou jq(cid:145)tour l(cid:146)kour. (cid:129)qhqo 3 O pq(cid:149)edqor tou Sulbouk(cid:148)ou enousiodote(cid:148)tai ma oq(cid:148)sei ta pq(cid:149)sypa pou e(cid:148)mai aql(cid:149)dia ma upocq(cid:145)xoum tg sulvym(cid:148)a up(cid:149) loqv(cid:147) amtakkac(cid:147)r epistok(cid:150)m, desle(cid:151)omtar tgm Joi- m(cid:149)tgta. Bqun(cid:146)kker, 10 La(cid:155)ou 1999. Cia to Sulbo(cid:151)kio O Pq(cid:149)edqor H. EICHEL